| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 4.82e-10 | 14 | 298 | 7 | GO:0005130 | |
| GeneOntologyMolecularFunction | filamin binding | 7.32e-09 | 29 | 298 | 8 | GO:0031005 | |
| GeneOntologyMolecularFunction | actin binding | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 SPTBN1 CEACAM6 SYNPO SPATA31C1 JMY CEACAM1 SPTBN5 DST MYPN DMD PDLIM2 MYOT GAS2L3 TRIOBP INO80 TLN1 MACF1 CROCC EPB41L1 MYBPC2 | 1.61e-08 | 479 | 298 | 26 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ABL2 PSG1 PSG3 MAP6 PSG4 PSG6 PSG9 SPTBN1 CEACAM6 SYNPO SPATA31C1 JMY CEACAM1 SPTBN5 DST KIF2B PTPRN STARD9 MYPN KIF14 DLEC1 DMD PDLIM2 MYOT ANK1 NRCAM GAS2L3 EPB41L5 ARFGEF1 TRIOBP GRIA1 SYBU INO80 KLC4 CCDC88C NKD2 TLN1 MACF1 SKA3 CROCC EPB41L1 MYBPC2 | 2.04e-08 | 1099 | 298 | 42 | GO:0008092 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.90e-08 | 34 | 298 | 8 | GO:0015125 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.07e-08 | 23 | 298 | 7 | GO:0034235 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.81e-07 | 29 | 298 | 7 | GO:0035325 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 CEACAM1 CASS4 RASA1 IRS2 CEACAM20 | 2.52e-06 | 149 | 298 | 12 | GO:1990782 |
| GeneOntologyMolecularFunction | glycolipid binding | 7.72e-06 | 49 | 298 | 7 | GO:0051861 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 9.48e-06 | 70 | 298 | 8 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.30e-05 | 73 | 298 | 8 | GO:0170055 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 6.02e-05 | 90 | 298 | 8 | GO:0008028 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDH26 SPTBN1 ITGA6 NFASC ITGAD DSCAML1 NLGN3 NEO1 DST PI4KA MYPN DMD VSIG10L2 MYOT NRCAM ADAMTS8 TLN1 DCHS1 GIGYF2 MACF1 TNR CDH3 | 1.03e-04 | 599 | 298 | 22 | GO:0050839 |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCA2 PSG1 PSG3 PSG4 PSG6 SLCO2B1 PSG9 CEACAM6 ABCA7 CEACAM1 ATG9A | 1.83e-04 | 196 | 298 | 11 | GO:0005319 |
| GeneOntologyMolecularFunction | myosin binding | 2.81e-04 | 85 | 298 | 7 | GO:0017022 | |
| GeneOntologyMolecularFunction | GTPase binding | RIN3 GGA2 MYCBP2 SPTBN1 SH3BP4 PTPRN RASA1 TRIOBP XPO4 GRIA1 RAB11FIP1 IPO4 RANBP17 RAB3IP RIMS1 | 3.59e-04 | 360 | 298 | 15 | GO:0051020 |
| GeneOntologyMolecularFunction | calcium ion binding | PRSS2 CDH26 REPS1 FAT2 DST NID1 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 RAB44 NKD2 CGREF1 VCAN DCHS1 MACF1 REPS2 CDH3 PCDHGA8 | 3.88e-04 | 749 | 298 | 24 | GO:0005509 |
| GeneOntologyMolecularFunction | protein kinase binding | HDAC9 HIF1A HDAC4 PSG1 PSG3 PSG4 PSG6 CDK12 PSG7 PSG9 CEACAM6 CEACAM1 MS4A2 MAVS NBEAL2 PKD1 KIF14 LRRC7 CASS4 RASA1 GRIA1 ATF2 CSPG4 IRS2 RIMS1 CEACAM20 | 6.71e-04 | 873 | 298 | 26 | GO:0019901 |
| GeneOntologyMolecularFunction | calmodulin binding | PSG1 PSG3 MAP6 PSG4 PSG6 PSG9 SPTBN1 CEACAM6 CEACAM1 CACNA1A FAS | 7.11e-04 | 230 | 298 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | PSG1 PSG3 PSG4 PSG6 SLCO2B1 PSG9 CEACAM6 CEACAM1 GRIA1 SLC13A3 | 1.14e-03 | 207 | 298 | 10 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | PSG1 PSG3 PSG4 PSG6 SLCO2B1 PSG9 CEACAM6 CEACAM1 GRIA1 SLC13A3 | 1.18e-03 | 208 | 298 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.19e-03 | 173 | 298 | 9 | GO:0070851 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.27e-03 | 210 | 298 | 10 | GO:0019903 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.31e-03 | 4 | 298 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | kinase binding | HDAC9 HIF1A HDAC4 PSG1 PSG3 PSG4 PSG6 CDK12 PSG7 PSG9 CEACAM6 CEACAM1 MS4A2 MAVS NBEAL2 PKD1 KIF14 LRRC7 CASS4 RASA1 GRIA1 FAS ATF2 CSPG4 IRS2 RIMS1 CEACAM20 | 1.42e-03 | 969 | 298 | 27 | GO:0019900 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDH26 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 DSCAML1 CEACAM1 FAT2 MYPN PKD1 PCDH18 SDK2 MYOT PCDHGC5 NRCAM PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 2.67e-19 | 187 | 300 | 27 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDH26 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 DSCAML1 CEACAM1 FAT2 MYPN PKD1 FLRT3 PCDH18 SDK2 MYOT PCDHGC5 NRCAM PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 ELFN1 DCHS1 MDGA1 CDH3 PCDHGA8 | 3.03e-16 | 313 | 300 | 30 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 CDH26 ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 ITGA6 CEACAM6 NFASC ITGAD DSCAML1 CEACAM1 NLGN3 NEO1 FAT2 ZNF608 MYPN PKD1 PKHD1 LRRC7 FLRT3 PCDH18 VSIG10L2 SDK2 MYOT PCDHGC5 NRCAM PCDHGA6 FAT3 PCDHB7 EPB41L5 PCDHAC1 PCDHA11 PCDHA10 FNDC3A PCDHA2 IGDCC4 ELFN1 TLN1 DCHS1 MDGA1 TNR CDH3 PCDHGA8 | 4.84e-11 | 1077 | 300 | 46 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.04e-10 | 14 | 300 | 7 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 7.48e-10 | 15 | 300 | 7 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 7.48e-10 | 15 | 300 | 7 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 7.48e-10 | 15 | 300 | 7 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 7.48e-10 | 15 | 300 | 7 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.31e-09 | 16 | 300 | 7 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.20e-09 | 17 | 300 | 7 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.20e-09 | 17 | 300 | 7 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 2.20e-09 | 17 | 300 | 7 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 3.56e-09 | 18 | 300 | 7 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 8.46e-09 | 20 | 300 | 7 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.25e-08 | 21 | 300 | 7 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.25e-08 | 21 | 300 | 7 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.25e-08 | 21 | 300 | 7 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.42e-08 | 32 | 300 | 8 | GO:0045779 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.82e-08 | 22 | 300 | 7 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.85e-08 | 33 | 300 | 8 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.39e-08 | 34 | 300 | 8 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.39e-08 | 34 | 300 | 8 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.58e-08 | 23 | 300 | 7 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.58e-08 | 23 | 300 | 7 | GO:0090331 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 3.05e-08 | 35 | 300 | 8 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 3.60e-08 | 24 | 300 | 7 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 3.60e-08 | 24 | 300 | 7 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 3.60e-08 | 24 | 300 | 7 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 4.93e-08 | 25 | 300 | 7 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 4.93e-08 | 25 | 300 | 7 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 8.89e-08 | 27 | 300 | 7 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.17e-07 | 28 | 300 | 7 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.52e-07 | 29 | 300 | 7 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.46e-07 | 45 | 300 | 8 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.50e-07 | 31 | 300 | 7 | GO:0010544 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 CDH26 ABL2 PSG1 MYCBP2 PSG3 PSG4 PSG6 PSG9 ITGA6 CEACAM6 NFASC SYNPO CSMD2 CEACAM1 NLGN3 DST PKHD1 FLRT3 CACNA1A SDK2 MYOT PCDHGC5 NRCAM EPB41L5 GRIA1 SYBU IGF1R ELFN1 TLN1 MACF1 TMEM108 MDGA1 TNR CDH3 INS-IGF2 | 2.84e-07 | 974 | 300 | 36 | GO:0034330 |
| GeneOntologyBiologicalProcess | fat cell proliferation | 3.16e-07 | 32 | 300 | 7 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.16e-07 | 32 | 300 | 7 | GO:0060312 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 3.51e-07 | 47 | 300 | 8 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 3.51e-07 | 47 | 300 | 8 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.97e-07 | 33 | 300 | 7 | GO:0030852 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.10e-06 | 38 | 300 | 7 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.33e-06 | 39 | 300 | 7 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.59e-06 | 40 | 300 | 7 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.89e-06 | 41 | 300 | 7 | GO:0002716 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 NES CDH26 ABL2 MYCBP2 MAP6 NFASC DSCAML1 NLGN3 ANOS1 NEO1 DST NBEAL2 MYPN PKHD1 PDZD8 FLRT3 DMD TSC22D4 SOX6 CACNA1A PLXNA3 MYOT NRCAM RASA1 FAT3 EPB41L5 TRIOBP CCDC88C IGF1R P2RX7 MACF1 TMEM108 RIMS1 ARHGEF26 TNR MUC3A CDH3 ZMYM3 | 1.93e-06 | 1194 | 300 | 39 | GO:0000902 |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.13e-06 | 59 | 300 | 8 | GO:0045671 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.24e-06 | 42 | 300 | 7 | GO:0090330 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.42e-06 | 60 | 300 | 8 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 2.42e-06 | 60 | 300 | 8 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.75e-06 | 61 | 300 | 8 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | HIF1A PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 LRIG2 NEO1 DDR2 ARFGEF1 IGF1R TNR | 3.83e-06 | 217 | 300 | 14 | GO:1903034 |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 4.23e-06 | 46 | 300 | 7 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 4.23e-06 | 46 | 300 | 7 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 4.91e-06 | 47 | 300 | 7 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 6.54e-06 | 49 | 300 | 7 | GO:0002837 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 6.54e-06 | 49 | 300 | 7 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 MAVS GIGYF2 INS-IGF2 | 6.54e-06 | 114 | 300 | 10 | GO:0045824 |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 7.13e-06 | 91 | 300 | 9 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 7.51e-06 | 50 | 300 | 7 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 7.88e-06 | 70 | 300 | 8 | GO:0045124 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 8.77e-06 | 71 | 300 | 8 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 8.77e-06 | 71 | 300 | 8 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 9.81e-06 | 52 | 300 | 7 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.12e-05 | 53 | 300 | 7 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 MAVS GIGYF2 MAPKBP1 INS-IGF2 | 1.36e-05 | 151 | 300 | 11 | GO:0002832 |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.59e-05 | 126 | 300 | 10 | GO:1903035 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.62e-05 | 56 | 300 | 7 | GO:0002418 | |
| GeneOntologyBiologicalProcess | cell growth | PRSS2 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 SH3BP4 NLGN3 KIF14 KAZALD1 FLRT3 TSC22D4 PLXNA3 NRCAM PI16 EPB41L5 INO80 CGREF1 MACF1 TMEM108 RIMS1 TNR | 1.64e-05 | 625 | 300 | 24 | GO:0016049 |
| GeneOntologyBiologicalProcess | regulation of behavior | NR2C2 HDAC4 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 INS-IGF2 | 1.82e-05 | 128 | 300 | 10 | GO:0050795 |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 2.13e-05 | 80 | 300 | 8 | GO:0046850 | |
| GeneOntologyBiologicalProcess | growth | BNC2 PRSS2 HIF1A ABL2 PSG1 MYCBP2 PSG3 PSG4 PSG6 PSG9 CEACAM6 ERVW-1 CEACAM1 SH3BP4 RTF1 NLGN3 KIF14 KAZALD1 FLRT3 DMD TSC22D4 PLXNA3 NRCAM PI16 GDF15 DDR2 EPB41L5 SALL4 INO80 ATF2 IGF1R CGREF1 GIGYF2 MACF1 TMEM108 RIMS1 TNR | 2.47e-05 | 1235 | 300 | 37 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 GDF15 IRS2 INS-IGF2 | 2.72e-05 | 134 | 300 | 10 | GO:0019217 |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 3.33e-05 | 85 | 300 | 8 | GO:1903670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 3.33e-05 | 85 | 300 | 8 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 PKHD1 CASS4 GDF15 DDR2 ARFGEF1 IGF1R IRS2 RUBCN INS-IGF2 | 3.38e-05 | 334 | 300 | 16 | GO:0051896 |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | RIN3 ABCA2 PSG1 PSG3 PSG4 PSG6 PSG9 KIAA0319L CEACAM6 CEACAM1 NLGN3 SMAP1 GRIA1 RABEP1 TMEM108 INS-IGF2 | 3.77e-05 | 337 | 300 | 16 | GO:0006898 |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 4.80e-05 | 66 | 300 | 7 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 5.29e-05 | 67 | 300 | 7 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | ABCA2 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 NR0B1 INS-IGF2 | 5.34e-05 | 145 | 300 | 10 | GO:0045833 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | EPHB3 HDAC9 SP3 HIF1A ABCA2 ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 SPTBN1 KIAA0319L CEACAM6 NFASC ERVW-1 CEACAM1 RTF1 NEO1 SUPT6H AMOT NBEAL2 MYPN NR0B1 PKD1 CACNA1A PLXNA3 SDK2 GDF15 FAT3 EPB41L5 PCDHA10 SALL4 RFX2 ATF2 E2F8 CSPG4 DCHS1 MACF1 INS-IGF2 MYBPC2 | 5.48e-05 | 1483 | 300 | 41 | GO:0048646 |
| GeneOntologyBiologicalProcess | vasculogenesis | 5.78e-05 | 118 | 300 | 9 | GO:0001570 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 6.41e-05 | 69 | 300 | 7 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | HDAC4 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 IER3 INS-IGF2 | 6.72e-05 | 149 | 300 | 10 | GO:0062014 |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane transport | 7.03e-05 | 70 | 300 | 7 | GO:0006893 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 7.03e-05 | 70 | 300 | 7 | GO:1900047 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 7.41e-05 | 95 | 300 | 8 | GO:0070527 | |
| GeneOntologyBiologicalProcess | receptor internalization | RIN3 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 GRIA1 RABEP1 INS-IGF2 | 7.59e-05 | 182 | 300 | 11 | GO:0031623 |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 8.43e-05 | 72 | 300 | 7 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 8.43e-05 | 72 | 300 | 7 | GO:0032692 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 9.21e-05 | 73 | 300 | 7 | GO:0042304 | |
| GeneOntologyBiologicalProcess | bone resorption | 9.93e-05 | 99 | 300 | 8 | GO:0045453 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | EPHB3 HIF1A ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 LRIG2 FLRT3 CASS4 RASA1 ADRM1 GDF15 DDR2 IGF1R CSPG4 GIGYF2 TMEM108 IRS2 REPS2 CDH3 INS-IGF2 | 1.03e-04 | 747 | 300 | 25 | GO:0007169 |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.09e-04 | 128 | 300 | 9 | GO:0034103 | |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 1.14e-04 | 18 | 300 | 4 | GO:0070593 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | EPHB3 ITGA6 CEACAM6 ITGAD FAT2 PKD1 PKHD1 KIF14 NID1 DMD CASS4 RASA1 EPB41L5 TRIOBP MSLNL TLN1 MACF1 | 1.15e-04 | 410 | 300 | 17 | GO:0031589 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.19e-04 | 76 | 300 | 7 | GO:0042269 | |
| GeneOntologyBiologicalProcess | feeding behavior | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 GDF15 GIGYF2 INS-IGF2 | 1.35e-04 | 162 | 300 | 10 | GO:0007631 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | NES HIF1A ABL2 MYCBP2 MAP6 VPS13C SPTBN1 SYNPO PTBP1 SPICE1 DDX11 SPTBN5 MAVS IER3 PKD1 SEC16A SHCBP1L PLXNA3 ANK1 RASA1 ARFGEF1 TRIOBP INO80 FAS ATP13A2 CCDC88C IGF1R LMAN1 P2RX7 RAB3IP FBXO43 RIMS1 SKA3 EIF4G3 CROCC RUBCN INS-IGF2 | 1.38e-04 | 1342 | 300 | 37 | GO:0033043 |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 1.50e-04 | 105 | 300 | 8 | GO:0042267 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.23e-09 | 16 | 301 | 7 | GO:0070021 | |
| GeneOntologyCellularComponent | adherens junction | CDH26 PSG1 PSG3 PSG4 PSG6 PSG9 ITGA6 CEACAM6 CEACAM1 FAT2 LRRC7 PDLIM2 EPB41L5 TLN1 CDH3 | 4.76e-07 | 212 | 301 | 15 | GO:0005912 |
| GeneOntologyCellularComponent | cell-cell junction | CDH26 PSG1 PSG3 PSG4 PSG6 PSG9 STARD10 ITGA6 CEACAM6 NFASC SYNPO CEACAM1 FAT2 DST AMOT LRRC7 FLRT3 PDLIM2 VSIG10L2 EPB41L5 GRIA1 PCDHA10 CCDC88C P2RX7 TLN1 CDH3 | 5.01e-07 | 591 | 301 | 26 | GO:0005911 |
| GeneOntologyCellularComponent | lateral plasma membrane | 6.83e-07 | 90 | 301 | 10 | GO:0016328 | |
| GeneOntologyCellularComponent | anchoring junction | CDH26 PSG1 PSG3 PSG4 PSG6 PSG9 STARD10 ITGA6 CEACAM6 NFASC SYNPO CEACAM1 FAT2 DST AMOT PI4KA LRRC7 FLRT3 DMD PDLIM2 VSIG10L2 CASS4 DDR2 EPB41L5 TRIOBP GRIA1 PCDHA10 PABPC1 CCDC88C P2RX7 TLN1 CSPG4 CDH3 | 5.07e-06 | 976 | 301 | 33 | GO:0070161 |
| GeneOntologyCellularComponent | basal plasma membrane | PSG1 PSG3 PSG4 PSG6 SLCO2B1 PSG9 ITGA6 CEACAM6 CEACAM1 DST PKD1 LRRC7 SLC4A7 ANK1 HCN4 SLC13A3 NKD2 | 1.65e-05 | 354 | 301 | 17 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | PSG1 PSG3 PSG4 PSG6 SLCO2B1 PSG9 ITGA6 CEACAM6 CEACAM1 PKD1 LRRC7 SLC4A7 ANK1 HCN4 SLC13A3 NKD2 | 1.78e-05 | 320 | 301 | 16 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | PSG1 PSG3 PSG4 PSG6 SLCO2B1 PSG9 ITGA6 CEACAM6 CEACAM1 DST PKD1 LRRC7 SLC4A7 ANK1 HCN4 SLC13A3 NKD2 | 3.78e-05 | 378 | 301 | 17 | GO:0045178 |
| GeneOntologyCellularComponent | cell projection membrane | PSG1 PSG3 PSG4 PSG6 PSG9 SPTBN1 CEACAM6 ABCA7 CEACAM1 PKD1 DMD ANK1 EPB41L5 GRIA1 TLN1 CSPG4 MACF1 CEACAM20 | 5.86e-05 | 431 | 301 | 18 | GO:0031253 |
| GeneOntologyCellularComponent | cell surface | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 ITGA6 CEACAM6 ITGAD ABCA7 DSCAML1 CEACAM1 NLGN3 ANOS1 NEO1 MS4A2 AMOT PKD1 PKHD1 DMD NRCAM GRIA1 FAS P2RX7 MSLNL VCAN TLN1 CSPG4 LY9 SLAMF7 MDGA1 TNR CEACAM20 | 6.82e-05 | 1111 | 301 | 33 | GO:0009986 |
| GeneOntologyCellularComponent | ciliary membrane | 8.63e-05 | 98 | 301 | 8 | GO:0060170 | |
| GeneOntologyCellularComponent | axon | ATP5MC1 RIN3 HIF1A MYCBP2 MAP6 SPTBN1 NFASC SYNPO DSCAML1 LRIG2 NEO1 DST PTPRN MYPN LRRC7 FLRT3 DMD MYOT ANK1 NRCAM HCN4 GRIA1 SYBU IGF1R P2RX7 ELFN1 TMEM108 MDGA1 | 9.75e-05 | 891 | 301 | 28 | GO:0030424 |
| GeneOntologyCellularComponent | plasma membrane protein complex | ABCA2 CDH26 PSG1 PSG3 PSG4 PSG6 PSG9 ITGA6 CEACAM6 ITGAD CHRNG CEACAM1 NEO1 MS4A2 DMD CACNA1A HCN4 BIRC2 GRIA1 FAS IGF1R DCHS1 CDH3 LILRA4 | 4.59e-04 | 785 | 301 | 24 | GO:0098797 |
| GeneOntologyCellularComponent | protein kinase complex | 8.25e-04 | 170 | 301 | 9 | GO:1902911 | |
| GeneOntologyCellularComponent | A band | 8.95e-04 | 52 | 301 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | cell leading edge | ABL2 SPTBN1 ABCA7 JMY DST AMOT DMD ANK1 RASA1 EPB41L5 GRIA1 PABPC1 TLN1 CSPG4 RAB3IP MACF1 ARHGEF26 | 9.99e-04 | 500 | 301 | 17 | GO:0031252 |
| GeneOntologyCellularComponent | sarcomere | HDAC4 SPTBN1 SYNPO DST MYPN DMD PDLIM2 MYOT ANK1 LMAN1 MYBPC2 | 1.02e-03 | 249 | 301 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | external side of plasma membrane | PSG1 PSG3 PSG4 PSG6 PSG9 ITGA6 CEACAM6 ITGAD CEACAM1 MS4A2 AMOT PKHD1 NRCAM FAS P2RX7 LY9 SLAMF7 | 1.49e-03 | 519 | 301 | 17 | GO:0009897 |
| GeneOntologyCellularComponent | Z disc | 1.58e-03 | 151 | 301 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | asymmetric synapse | SPTBN1 SYNPO CSMD2 NLGN3 NEO1 DST LRRC7 FLRT3 DMD NRCAM GRIA1 ELFN1 MACF1 TMEM108 RIMS1 EPB41L1 | 1.60e-03 | 477 | 301 | 16 | GO:0032279 |
| GeneOntologyCellularComponent | neuron to neuron synapse | SPTBN1 SYNPO CSMD2 NLGN3 NEO1 DST LRRC7 FLRT3 DMD NRCAM GRIA1 ELFN1 MACF1 TMEM108 RIMS1 TNR EPB41L1 | 1.62e-03 | 523 | 301 | 17 | GO:0098984 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | PSG1 PSG3 PSG4 PSG6 PSG9 ITGA6 CEACAM6 ITGAD CHRNG CEACAM1 BIRC2 GRIA1 IGF1R | 1.79e-03 | 350 | 301 | 13 | GO:0098802 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.02e-03 | 157 | 301 | 8 | GO:1902554 | |
| GeneOntologyCellularComponent | myofibril | HDAC4 SPTBN1 SYNPO DST MYPN DMD PDLIM2 MYOT ANK1 LMAN1 MYBPC2 | 2.12e-03 | 273 | 301 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | postsynaptic density | SPTBN1 SYNPO CSMD2 NEO1 DST LRRC7 FLRT3 DMD NRCAM GRIA1 ELFN1 MACF1 TMEM108 RIMS1 EPB41L1 | 2.41e-03 | 451 | 301 | 15 | GO:0014069 |
| MousePheno | decreased skeletal muscle cell glucose uptake | 5.54e-09 | 35 | 241 | 9 | MP:0031618 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 6.97e-09 | 17 | 241 | 7 | MP:0031047 | |
| MousePheno | increased insulin secretion | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 KCNH6 ARFGEF3 IRS2 INS-IGF2 | 1.06e-08 | 64 | 241 | 11 | MP:0003058 |
| MousePheno | decreased muscle cell glucose uptake | 1.57e-08 | 39 | 241 | 9 | MP:0030022 | |
| MousePheno | decreased cellular glucose uptake | PSG1 PSG3 PSG4 PSG6 PSG9 MGAT4A CEACAM6 CEACAM1 ARFGEF3 INS-IGF2 | 1.96e-08 | 53 | 241 | 10 | MP:0003926 |
| MousePheno | abnormal skeletal muscle triglyceride level | 3.89e-08 | 31 | 241 | 8 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 3.89e-08 | 31 | 241 | 8 | MP:0008964 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.93e-08 | 21 | 241 | 7 | MP:0031415 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 8.93e-08 | 47 | 241 | 9 | MP:0031617 | |
| MousePheno | decreased fatty acid oxidation | 1.12e-07 | 24 | 241 | 7 | MP:0014172 | |
| MousePheno | abnormal muscle triglyceride level | 1.39e-07 | 36 | 241 | 8 | MP:0031412 | |
| MousePheno | abnormal carbon dioxide production | NR2C2 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 CSPG4 INS-IGF2 | 2.02e-07 | 67 | 241 | 10 | MP:0008962 |
| MousePheno | abnormal wound healing | NCOA6 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 DST IER3 NBEAL2 DDR2 CCDC88C VCAN IRS2 TINCR | 2.30e-07 | 193 | 241 | 16 | MP:0005023 |
| MousePheno | increased abdominal fat pad weight | 2.75e-07 | 27 | 241 | 7 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.61e-07 | 28 | 241 | 7 | MP:0020950 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 7.21e-07 | 44 | 241 | 8 | MP:0031023 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 7.97e-07 | 60 | 241 | 9 | MP:0009790 | |
| MousePheno | abnormal muscle cell glucose uptake | 2.08e-06 | 67 | 241 | 9 | MP:0004130 | |
| MousePheno | abnormal fatty acid oxidation | 3.65e-06 | 54 | 241 | 8 | MP:0010953 | |
| MousePheno | insulin resistance | TRPC4AP PSG1 PSG3 PSG4 PSG6 PSG9 MGAT4A CEACAM6 CEACAM1 CREBBP ARFGEF3 CSPG4 IRS2 INS-IGF2 | 8.13e-06 | 197 | 241 | 14 | MP:0005331 |
| MousePheno | polyphagia | 9.27e-06 | 80 | 241 | 9 | MP:0001433 | |
| MousePheno | abnormal lipid oxidation | 9.30e-06 | 61 | 241 | 8 | MP:0010951 | |
| MousePheno | abnormal cellular glucose uptake | PSG1 PSG3 PSG4 PSG6 PSG9 MGAT4A CEACAM6 CEACAM1 ARFGEF3 INS-IGF2 | 1.02e-05 | 102 | 241 | 10 | MP:0003925 |
| MousePheno | decreased susceptibility to viral infection | PSG1 PSG3 PSG4 PSG6 PSG9 KIAA0319L CEACAM6 CEACAM1 DMD IGDCC4 JCHAIN | 1.05e-05 | 125 | 241 | 11 | MP:0002410 |
| MousePheno | decreased susceptibility to Riboviria infection | 1.14e-05 | 82 | 241 | 9 | MP:0020914 | |
| MousePheno | decreased birth body size | NES BNC2 NCOA6 SP3 GGA2 MYCBP2 ZNF462 KCNJ13 KMT2A DMTF1 ANK1 ADRM1 IGF1R IRS2 GREB1 | 1.21e-05 | 232 | 241 | 15 | MP:0009703 |
| MousePheno | abnormal birth body size | NES BNC2 NCOA6 SP3 GGA2 MYCBP2 ZNF462 KCNJ13 KMT2A DMTF1 ANK1 ADRM1 IGF1R IRS2 GREB1 | 1.56e-05 | 237 | 241 | 15 | MP:0009701 |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.92e-05 | 49 | 241 | 7 | MP:0020948 | |
| MousePheno | increased food intake | HDAC4 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 SAP130 GDF15 P2RX7 IRS2 INS-IGF2 | 2.43e-05 | 189 | 241 | 13 | MP:0011939 |
| MousePheno | decreased aggression | 3.25e-05 | 53 | 241 | 7 | MP:0005656 | |
| MousePheno | abnormal vascular wound healing | 3.56e-05 | 73 | 241 | 8 | MP:0004883 | |
| MousePheno | abnormal glycogen homeostasis | HIF1A MAN2C1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 CREBBP IRS2 | 3.97e-05 | 144 | 241 | 11 | MP:0005438 |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 4.25e-05 | 120 | 241 | 10 | MP:0009786 | |
| MousePheno | decreased oxygen consumption | 6.31e-05 | 79 | 241 | 8 | MP:0005290 | |
| MousePheno | abnormal colon morphology | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 RASA1 SALL4 ARAF HR | 6.51e-05 | 152 | 241 | 11 | MP:0000495 |
| MousePheno | abnormal susceptibility to Riboviria infection | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 MAVS DMD FAS ATF2 IGDCC4 | 9.28e-05 | 186 | 241 | 12 | MP:0020912 |
| MousePheno | decreased respiratory quotient | 1.19e-04 | 110 | 241 | 9 | MP:0010379 | |
| MousePheno | increased total body fat amount | PSG1 PSG3 PSG4 PSG6 PSG9 KIAA0319L CEACAM6 CEACAM1 ZNF462 TMEM129 DMD REC8 ADRM1 GDF15 FNDC3A GZF1 TMEM108 IRS2 TOPORS | 1.42e-04 | 424 | 241 | 19 | MP:0010024 |
| MousePheno | obese | 1.46e-04 | 113 | 241 | 9 | MP:0001261 | |
| MousePheno | abnormal pancreatic beta cell physiology | PSG1 PSG3 PSG4 PSG6 PSG9 VPS13C CEACAM6 CEACAM1 KCNH6 ARFGEF3 IRS2 INS-IGF2 | 1.52e-04 | 196 | 241 | 12 | MP:0003562 |
| MousePheno | abnormal insulin secretion | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 KCNH6 ARFGEF3 IRS2 INS-IGF2 | 1.86e-04 | 171 | 241 | 11 | MP:0003564 |
| MousePheno | abnormal endocrine gland physiology | PSG1 PSG3 PSG4 PSG6 PSG9 VPS13C CEACAM6 BIRC6 CEACAM1 KCNH6 PKD1 C14orf93 FAS ARFGEF3 IRS2 INS-IGF2 HR | 1.90e-04 | 363 | 241 | 17 | MP:0013561 |
| MousePheno | abnormal endocrine pancreas physiology | PSG1 PSG3 PSG4 PSG6 PSG9 VPS13C CEACAM6 CEACAM1 KCNH6 ARFGEF3 IRS2 INS-IGF2 | 2.02e-04 | 202 | 241 | 12 | MP:0010147 |
| MousePheno | abnormal endocrine pancreas secretion | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 KCNH6 ARFGEF3 IRS2 INS-IGF2 | 2.39e-04 | 176 | 241 | 11 | MP:0014195 |
| MousePheno | impaired glucose tolerance | NR2C2 PSG1 PSG3 PSG4 PSG6 PSG9 VPS13C MGAT4A CEACAM6 CEACAM1 ZNF462 KCNH6 PTPRN NACC1 CREBBP ARFGEF3 CSPG4 IRS2 MAPKBP1 INS-IGF2 | 2.50e-04 | 480 | 241 | 20 | MP:0005293 |
| MousePheno | increased circulating leptin level | 3.12e-04 | 125 | 241 | 9 | MP:0005669 | |
| MousePheno | abnormal muscle morphology | HDAC9 NCOA6 HIF1A PSG1 MYCBP2 PSG3 PSG4 PSG6 PSG9 SPTBN1 CEACAM6 CHRNG CEACAM1 MGAT2 DST IER3 MYPN PKD1 KMT2A DMD MPO ANK1 GAS2L3 FAT3 DDR2 SALL4 FAS CREBBP ARAF IGF1R IRS2 KAT6B INS-IGF2 SOD3 MYBPC2 | 3.33e-04 | 1106 | 241 | 35 | MP:0002108 |
| MousePheno | abnormal pancreas secretion | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 KCNH6 ARFGEF3 IRS2 INS-IGF2 | 3.35e-04 | 183 | 241 | 11 | MP:0002694 |
| MousePheno | abnormal response to injury | NCOA6 TRPC4AP PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 HSPA12A ADPRS DST IER3 NBEAL2 MPO CACNA1A GDF15 DDR2 CCDC88C VCAN IRS2 TINCR SOD3 | 3.40e-04 | 607 | 241 | 23 | MP:0005164 |
| MousePheno | abnormal susceptibility to viral infection | PSG1 PSG3 PSG4 PSG6 PSG9 KIAA0319L CEACAM6 CEACAM1 MAVS DMD FAS ATF2 IGDCC4 JCHAIN | 3.51e-04 | 279 | 241 | 14 | MP:0020185 |
| MousePheno | abnormal aggression-related behavior | 3.51e-04 | 127 | 241 | 9 | MP:0002061 | |
| MousePheno | increased lean body mass | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 ADPRS PDZD8 DMD PCDH18 DDR2 EPB41L5 ORC1 RAB3IP EPB41L1 | 4.34e-04 | 354 | 241 | 16 | MP:0003960 |
| MousePheno | decreased susceptibility to infection | PSG1 PSG3 PSG4 PSG6 PSG9 KIAA0319L CEACAM6 ITGAD CEACAM1 DMD ANK1 IGDCC4 JCHAIN | 4.90e-04 | 255 | 241 | 13 | MP:0002409 |
| MousePheno | abnormal oxygen consumption | NR2C2 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 CREBBP CSPG4 INS-IGF2 | 5.74e-04 | 195 | 241 | 11 | MP:0005288 |
| MousePheno | arrest of male meiosis | 7.16e-04 | 140 | 241 | 9 | MP:0008261 | |
| Domain | IGc2 | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM IGDCC4 MDGA1 CEACAM20 LILRA4 MYBPC2 | 2.62e-11 | 235 | 296 | 22 | SM00408 |
| Domain | Ig_sub2 | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM IGDCC4 MDGA1 CEACAM20 LILRA4 MYBPC2 | 2.62e-11 | 235 | 296 | 22 | IPR003598 |
| Domain | - | EPHB3 PSG1 MYCBP2 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 ANOS1 NEO1 MYPN PKHD1 KAZALD1 FLRT3 PLXNA3 SDK2 MYOT NRCAM TAPBPL FNDC3A IGDCC4 IGF1R VCAN LY9 SLAMF7 MDGA1 TNR CEACAM20 LILRA4 MYBPC2 | 4.58e-10 | 663 | 296 | 35 | 2.60.40.10 |
| Domain | Cadherin_CS | CDH26 FAT2 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 1.93e-09 | 109 | 296 | 14 | IPR020894 |
| Domain | Ig-like_fold | EPHB3 PSG1 MYCBP2 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 ANOS1 NEO1 MYPN PKHD1 KAZALD1 FLRT3 PLXNA3 SDK2 MYOT NRCAM TAPBPL FNDC3A IGDCC4 IGF1R VCAN LY9 SLAMF7 MDGA1 TNR CEACAM20 LILRA4 MYBPC2 | 2.39e-09 | 706 | 296 | 35 | IPR013783 |
| Domain | CADHERIN_1 | CDH26 FAT2 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 3.12e-09 | 113 | 296 | 14 | PS00232 |
| Domain | Cadherin | CDH26 FAT2 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 3.12e-09 | 113 | 296 | 14 | PF00028 |
| Domain | - | CDH26 FAT2 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 3.51e-09 | 114 | 296 | 14 | 2.60.40.60 |
| Domain | CADHERIN_2 | CDH26 FAT2 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 3.51e-09 | 114 | 296 | 14 | PS50268 |
| Domain | IG | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM TAPBPL IGDCC4 VCAN LY9 SLAMF7 MDGA1 CEACAM20 LILRA4 MYBPC2 | 3.78e-09 | 421 | 296 | 26 | SM00409 |
| Domain | Ig_sub | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM TAPBPL IGDCC4 VCAN LY9 SLAMF7 MDGA1 CEACAM20 LILRA4 MYBPC2 | 3.78e-09 | 421 | 296 | 26 | IPR003599 |
| Domain | CA | CDH26 FAT2 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 3.94e-09 | 115 | 296 | 14 | SM00112 |
| Domain | Cadherin-like | CDH26 FAT2 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 4.42e-09 | 116 | 296 | 14 | IPR015919 |
| Domain | Cadherin | CDH26 FAT2 PCDH18 PCDHGC5 PCDHGA6 FAT3 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 DCHS1 CDH3 PCDHGA8 | 5.53e-09 | 118 | 296 | 14 | IPR002126 |
| Domain | ig | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 SDK2 NRCAM MDGA1 CEACAM20 LILRA4 | 6.40e-08 | 190 | 296 | 16 | PF00047 |
| Domain | Immunoglobulin | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 SDK2 NRCAM MDGA1 CEACAM20 LILRA4 | 6.40e-08 | 190 | 296 | 16 | IPR013151 |
| Domain | IG_LIKE | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM TAPBPL IGDCC4 VCAN LY9 SLAMF7 MDGA1 CEACAM20 LILRA4 MYBPC2 | 8.55e-08 | 491 | 296 | 26 | PS50835 |
| Domain | Ig-like_dom | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM TAPBPL IGDCC4 VCAN LY9 SLAMF7 MDGA1 CEACAM20 LILRA4 MYBPC2 | 1.37e-07 | 503 | 296 | 26 | IPR007110 |
| Domain | Ig_2 | 2.21e-07 | 73 | 296 | 10 | PF13895 | |
| Domain | FN3 | EPHB3 KIAA0319L NFASC DSCAML1 ANOS1 NEO1 FLRT3 SDK2 NRCAM FNDC3A IGDCC4 IGF1R MDGA1 TNR MYBPC2 | 2.72e-07 | 185 | 296 | 15 | SM00060 |
| Domain | Ig_I-set | CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM IGDCC4 MDGA1 CEACAM20 MYBPC2 | 3.84e-07 | 190 | 296 | 15 | IPR013098 |
| Domain | I-set | CEACAM6 NFASC DSCAML1 CEACAM1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM IGDCC4 MDGA1 CEACAM20 MYBPC2 | 3.84e-07 | 190 | 296 | 15 | PF07679 |
| Domain | Cadherin_2 | PCDH18 PCDHGC5 PCDHGA6 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 PCDHGA8 | 8.21e-07 | 65 | 296 | 9 | PF08266 |
| Domain | Cadherin_N | PCDH18 PCDHGC5 PCDHGA6 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 PCDHGA8 | 8.21e-07 | 65 | 296 | 9 | IPR013164 |
| Domain | FN3_dom | EPHB3 KIAA0319L NFASC DSCAML1 ANOS1 NEO1 FLRT3 SDK2 NRCAM FNDC3A IGDCC4 IGF1R MDGA1 TNR MYBPC2 | 1.29e-06 | 209 | 296 | 15 | IPR003961 |
| Domain | Cadherin_tail | 1.60e-06 | 37 | 296 | 7 | PF15974 | |
| Domain | Cadherin_CBD | 1.60e-06 | 37 | 296 | 7 | IPR031904 | |
| Domain | fn3 | EPHB3 NFASC DSCAML1 ANOS1 NEO1 FLRT3 SDK2 NRCAM FNDC3A IGDCC4 IGF1R TNR MYBPC2 | 1.93e-06 | 162 | 296 | 13 | PF00041 |
| Domain | FN3 | EPHB3 NFASC DSCAML1 ANOS1 NEO1 FLRT3 SDK2 NRCAM FNDC3A IGDCC4 IGF1R MDGA1 TNR MYBPC2 | 3.70e-06 | 199 | 296 | 14 | PS50853 |
| Domain | Spectrin | 2.57e-05 | 23 | 296 | 5 | PF00435 | |
| Domain | ACTININ_2 | 2.57e-05 | 23 | 296 | 5 | PS00020 | |
| Domain | ACTININ_1 | 2.57e-05 | 23 | 296 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.57e-05 | 23 | 296 | 5 | IPR001589 | |
| Domain | CH | 7.42e-05 | 65 | 296 | 7 | SM00033 | |
| Domain | GAR | 7.61e-05 | 6 | 296 | 3 | PS51460 | |
| Domain | GAS_dom | 7.61e-05 | 6 | 296 | 3 | IPR003108 | |
| Domain | GAS2 | 7.61e-05 | 6 | 296 | 3 | PF02187 | |
| Domain | - | 7.61e-05 | 6 | 296 | 3 | 3.30.920.20 | |
| Domain | GAS2 | 7.61e-05 | 6 | 296 | 3 | SM00243 | |
| Domain | Ig_V-set | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 DSCAML1 CEACAM1 TAPBPL VCAN SLAMF7 | 8.29e-05 | 199 | 296 | 12 | IPR013106 |
| Domain | Spectrin_repeat | 8.40e-05 | 29 | 296 | 5 | IPR002017 | |
| Domain | CH | 1.19e-04 | 70 | 296 | 7 | PF00307 | |
| Domain | - | 1.31e-04 | 71 | 296 | 7 | 1.10.418.10 | |
| Domain | SPEC | 1.37e-04 | 32 | 296 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.37e-04 | 32 | 296 | 5 | IPR018159 | |
| Domain | CH | 1.56e-04 | 73 | 296 | 7 | PS50021 | |
| Domain | V-set | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM6 CEACAM1 TAPBPL VCAN SLAMF7 | 1.76e-04 | 184 | 296 | 11 | PF07686 |
| Domain | CH-domain | 1.85e-04 | 75 | 296 | 7 | IPR001715 | |
| Domain | Cadherin_C | 5.09e-04 | 42 | 296 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 5.09e-04 | 42 | 296 | 5 | PF16492 | |
| Domain | HDAC4_Gln | 7.43e-04 | 3 | 296 | 2 | PF12203 | |
| Domain | RFX1_trans_act | 7.43e-04 | 3 | 296 | 2 | IPR007668 | |
| Domain | RFX1_trans_act | 7.43e-04 | 3 | 296 | 2 | PF04589 | |
| Domain | Hist_deacetylase_Gln_rich_N | 7.43e-04 | 3 | 296 | 2 | IPR024643 | |
| Domain | DCB_dom | 1.47e-03 | 4 | 296 | 2 | IPR032629 | |
| Domain | Histone_deAcase_II_euk | 1.47e-03 | 4 | 296 | 2 | IPR017320 | |
| Domain | DCB | 1.47e-03 | 4 | 296 | 2 | PF16213 | |
| Domain | Neurofascin/L1/NrCAM_C | 1.47e-03 | 4 | 296 | 2 | IPR026966 | |
| Domain | Sec7_C | 1.47e-03 | 4 | 296 | 2 | IPR015403 | |
| Domain | DUF1981 | 1.47e-03 | 4 | 296 | 2 | PF09324 | |
| Domain | Bravo_FIGEY | 1.47e-03 | 4 | 296 | 2 | PF13882 | |
| Domain | FERM_N | 1.76e-03 | 33 | 296 | 4 | IPR018979 | |
| Domain | FERM_N | 1.76e-03 | 33 | 296 | 4 | PF09379 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | PRSS2 PSG1 PSG3 PSG4 PSG6 PSG9 ITGA6 CEACAM6 ITGAD CEACAM1 NID1 DDR2 VCAN TNR | 2.94e-05 | 258 | 208 | 14 | MM14572 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.29e-05 | 31 | 208 | 5 | M877 | |
| Pathway | REACTOME_NEUROFASCIN_INTERACTIONS | 1.06e-04 | 7 | 208 | 3 | M27380 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.06e-04 | 99 | 208 | 8 | MM14624 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | REPS1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 RASA1 ARAF REPS2 | 1.10e-04 | 188 | 208 | 11 | MM15828 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES NCOA6 DENND4A ABL2 HDAC4 MYCBP2 SPTBN1 SPICE1 SH3BP4 ZCCHC14 DST AMOT STARD9 PI4KA SEC16A KIF14 KMT2A TSC22D4 SLC4A7 EPB41L5 MLXIP RAB11FIP1 KLC4 PABPC1 ARAF E2F8 ARFGEF3 CCDC88C NHSL1 IGF1R NKD2 AASS RABEP1 GIGYF2 MACF1 IRS2 SKA3 EIF4G3 SRRM2 EPB41L1 | 1.04e-17 | 861 | 306 | 40 | 36931259 |
| Pubmed | NCOA6 MYCBP2 CDK12 NFASC SNRK BIRC6 DSCAML1 RTF1 ZNF462 ZCCHC14 DST ZNF608 AMOT SEC16A TRIOBP FNDC3A RBM12 TLN1 GIGYF2 MACF1 PCNX1 KAT6B | 9.72e-17 | 225 | 306 | 22 | 12168954 | |
| Pubmed | NES HDAC4 MYCBP2 MAP6 SPTBN1 NFASC SYNPO ZNF318 SPICE1 ZNF462 LRIG2 NLGN3 DST PI4KA SEC16A LRRC7 PRRC2A CACNA1A NRCAM HCN4 WDR7 NACC1 ZNF618 TRIOBP GRIA1 IPO4 PABPC1 PREPL CCDC88C P2RX7 RABEP1 RAB3IP DCHS1 GIGYF2 MACF1 RIMS1 ARHGEF26 TNR EPB41L1 TP53BP1 | 4.64e-16 | 963 | 306 | 40 | 28671696 | |
| Pubmed | 9.40e-14 | 14 | 306 | 8 | 37531413 | ||
| Pubmed | 9.40e-14 | 14 | 306 | 8 | 1648219 | ||
| Pubmed | 9.40e-14 | 14 | 306 | 8 | 25908210 | ||
| Pubmed | 2.00e-13 | 15 | 306 | 8 | 16044082 | ||
| Pubmed | NR2C2 MYCBP2 BCORL1 ZNF318 BIRC6 PRDM2 ZNF462 DST GSE1 ZNF608 AMOT NR0B1 SEC16A KIF14 NACC1 RFX1 ARAF LMAN1 ZNF532 RABEP1 GIGYF2 IRS2 SKA3 ZMYM3 | 5.60e-13 | 418 | 306 | 24 | 34709266 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 RIN3 ABCA2 REPS1 MYCBP2 CDK12 KIAA0319L FHIP1B BIRC6 ABCA7 SH3BP4 ZCCHC14 TMEM129 DST PI4KA NBEAL2 BANP PKD1 SEC16A PDZD8 KAZALD1 WDR90 ATG9A PLXNA3 TMEM158 INO80 MLXIP ATP13A2 ORC1 CCDC88C NHSL1 IGF1R TLN1 CSPG4 PCNX1 IRS2 MAPKBP1 HR | 9.25e-13 | 1105 | 306 | 38 | 35748872 |
| Pubmed | 2.28e-12 | 19 | 306 | 8 | 22496641 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.25e-12 | 13 | 306 | 7 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.25e-12 | 13 | 306 | 7 | 19273835 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 20044046 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 32150576 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.25e-12 | 13 | 306 | 7 | 12832451 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 25406283 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 8380065 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 1279194 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 25724769 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.25e-12 | 13 | 306 | 7 | 22092845 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.25e-12 | 13 | 306 | 7 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.25e-12 | 13 | 306 | 7 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.25e-12 | 13 | 306 | 7 | 23800882 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.25e-12 | 13 | 306 | 7 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.25e-12 | 13 | 306 | 7 | 39168268 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 8402684 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.25e-12 | 13 | 306 | 7 | 21949477 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 26219866 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 2133556 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.25e-12 | 13 | 306 | 7 | 19358828 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.25e-12 | 13 | 306 | 7 | 34058224 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.25e-12 | 13 | 306 | 7 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.25e-12 | 13 | 306 | 7 | 25972571 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.25e-12 | 13 | 306 | 7 | 15220458 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 18843289 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 15207636 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 21081647 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 11133662 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 11483763 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 18003729 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.25e-12 | 13 | 306 | 7 | 27695943 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.25e-12 | 13 | 306 | 7 | 16638824 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.25e-12 | 13 | 306 | 7 | 21670291 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 22162753 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 2702644 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 11801635 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 21760897 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 1719235 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 16619040 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.25e-12 | 13 | 306 | 7 | 8209741 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 32521208 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.25e-12 | 13 | 306 | 7 | 29967450 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 1653760 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 32169849 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.25e-12 | 13 | 306 | 7 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.25e-12 | 13 | 306 | 7 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.25e-12 | 13 | 306 | 7 | 15316023 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 15331748 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.25e-12 | 13 | 306 | 7 | 22406619 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 7628460 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 19008452 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 2164599 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 29396368 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.25e-12 | 13 | 306 | 7 | 33352461 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 38381498 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 1633107 | ||
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.25e-12 | 13 | 306 | 7 | 32027621 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.25e-12 | 13 | 306 | 7 | 27777319 | |
| Pubmed | 6.25e-12 | 13 | 306 | 7 | 18848945 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.24e-11 | 14 | 306 | 7 | 34666041 | |
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 34619794 | ||
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 8896983 | ||
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 22962327 | ||
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 17623671 | ||
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.24e-11 | 14 | 306 | 7 | 18794798 | |
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 23469261 | ||
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 18454175 | ||
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 29907459 | ||
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 36719377 | ||
| Pubmed | 1.24e-11 | 14 | 306 | 7 | 28567513 | ||
| Interaction | YWHAH interactions | NES NCOA6 RIN3 ABCA2 DENND4A ABL2 HDAC4 MYCBP2 SPTBN1 SRSF12 SH3BP4 ZCCHC14 DST AMOT STARD9 PI4KA SEC16A KIF14 KMT2A ATG9A TSC22D4 SLC4A7 EPB41L5 MLXIP RAB11FIP1 KLC4 CREBBP ARAF E2F8 ARFGEF3 CCDC88C NHSL1 NKD2 AASS RABEP1 GIGYF2 MACF1 IRS2 RIMS1 SKA3 EIF4G3 SRRM2 RUBCN EPB41L1 | 1.82e-09 | 1102 | 298 | 44 | int:YWHAH |
| Interaction | YWHAG interactions | NCOA6 DENND4A ABL2 HDAC4 MYCBP2 CDK12 SPTBN1 SYNPO SPICE1 SRSF12 SH3BP4 DST AMOT STARD9 PI4KA SEC16A KIF14 KMT2A ATG9A TSC22D4 SLC4A7 EPB41L5 MLXIP RAB11FIP1 KLC4 ATF2 PABPC1 ARAF E2F8 LRCH3 CCDC88C NHSL1 IGF1R NKD2 AASS RABEP1 GIGYF2 MACF1 IRS2 SKA3 EIF4G3 SRRM2 RUBCN ZMYM3 EPB41L1 | 2.59e-08 | 1248 | 298 | 45 | int:YWHAG |
| Interaction | SFN interactions | HDAC9 NCOA6 HIF1A DENND4A ABL2 HDAC4 MYCBP2 SPTBN1 SH3BP4 DST AMOT BANP KIF14 KMT2A SAP130 SLC4A7 EPB41L5 RAB11FIP1 KLC4 ATF2 PABPC1 ARAF CCDC88C IGF1R AASS RAB3IP MACF1 IRS2 SKA3 SRRM2 | 1.53e-07 | 692 | 298 | 30 | int:SFN |
| Interaction | LGALS1 interactions | RIN3 ABCA2 TRPC4AP PSG1 KIAA0319L ITGA6 NLGN3 NEO1 KIF14 ATG9A SDK2 NRCAM FAT3 IGDCC4 IGF1R LMAN1 VCAN CSPG4 SLAMF7 | 5.78e-07 | 332 | 298 | 19 | int:LGALS1 |
| Interaction | PSG1 interactions | 7.63e-07 | 51 | 298 | 8 | int:PSG1 | |
| Interaction | TOP3B interactions | NCOA6 RIN3 ABCA2 REPS1 HDAC4 MYCBP2 CDK12 KIAA0319L FHIP1B BIRC6 ABCA7 SH3BP4 ZCCHC14 TMEM129 ANOS1 DST PI4KA NBEAL2 BANP PKD1 SEC16A KIF14 PDZD8 KAZALD1 WDR90 ATG9A PRRC2A PLXNA3 TMEM158 INO80 MLXIP IPO4 ATP13A2 PABPC1 GRSF1 ORC1 CCDC88C NHSL1 IGF1R TLN1 CSPG4 PCNX1 IRS2 MAPKBP1 TP53BP1 HR | 1.07e-06 | 1470 | 298 | 46 | int:TOP3B |
| Interaction | YWHAB interactions | RIN3 DENND4A ABL2 HDAC4 MYCBP2 SPTBN1 SRSF12 SH3BP4 DST AMOT STARD9 KIF14 KMT2A ATG9A SAP130 SLC4A7 ADRM1 NELFA EPB41L5 MLXIP RAB11FIP1 KLC4 ATF2 ARAF E2F8 CCDC88C NHSL1 IGF1R NKD2 AASS RABEP1 GIGYF2 MACF1 IRS2 SRRM2 EPB41L1 | 1.08e-06 | 1014 | 298 | 36 | int:YWHAB |
| Interaction | CEACAM7 interactions | 1.58e-06 | 7 | 298 | 4 | int:CEACAM7 | |
| Interaction | BAG2 interactions | NCOA6 NR2C2 HIF1A ABL2 HDAC4 VPS13C BCORL1 PSMC4 ZNF318 RTF1 MAVS SUPT6H AMOT KIF14 REC8 SMAP1 FAS RFX1 CREBBP ARAF LMAN1 TLN1 GREB1 SKA3 EIF4G3 SRRM2 | 2.10e-06 | 622 | 298 | 26 | int:BAG2 |
| Interaction | PSG4 interactions | 3.13e-06 | 8 | 298 | 4 | int:PSG4 | |
| Interaction | PHF21A interactions | SP3 MYCBP2 BCORL1 ZNF318 BIRC6 DST GSE1 AMOT BANP SEC16A KIF14 ARAF LMAN1 RABEP1 GIGYF2 IRS2 SKA3 ZMYM3 | 3.91e-06 | 343 | 298 | 18 | int:PHF21A |
| Interaction | PXN interactions | ABL2 ITGA6 BIRC6 CEACAM1 SPICE1 PI4KA PKD1 SEC16A KIF14 DYNC1I2 RASA1 PABPC1 IGF1R P2RX7 TLN1 MACF1 REPS2 | 1.09e-05 | 334 | 298 | 17 | int:PXN |
| Interaction | YWHAZ interactions | HDAC9 NR2C2 RIN3 DENND4A ABL2 HDAC4 MYCBP2 MAP6 SPTBN1 SYNPO SH3BP4 DST STARD9 NBEAL2 KIF14 KMT2A ATG9A TSC22D4 ANKRD40 PRRC2A SLC4A7 WDR7 NELFA MLXIP RAB11FIP1 KLC4 ARAF E2F8 CCDC88C NHSL1 IGF1R NKD2 AASS RABEP1 GIGYF2 MACF1 IRS2 RUBCN EPB41L1 TP53BP1 | 1.23e-05 | 1319 | 298 | 40 | int:YWHAZ |
| Interaction | PSG3 interactions | 1.46e-05 | 22 | 298 | 5 | int:PSG3 | |
| Interaction | RAB11A interactions | DENND4A HDAC4 VPS13C SPTBN1 ITGA6 BIRC6 DST MAVS PI4KA NBEAL2 SEC16A PDZD8 SDK2 SLC4A7 WDR7 EPB41L5 ARFGEF1 GRIA1 FNDC3A RAB11FIP1 KLC4 ATF2 ARAF CNNM3 IGF1R LMAN1 RABEP1 RAB3IP EPB41L1 | 1.73e-05 | 830 | 298 | 29 | int:RAB11A |
| Interaction | ASF1A interactions | NCOA6 NR2C2 HDAC4 BCORL1 PRDM2 GSE1 KMT2A SAP130 SOX6 NELFA IPO4 FAS RIF1 SUGP1 | 2.20e-05 | 249 | 298 | 14 | int:ASF1A |
| Interaction | NUP210P1 interactions | 3.33e-05 | 42 | 298 | 6 | int:NUP210P1 | |
| Interaction | RHOQ interactions | ABL2 VPS13C SPTBN1 ITGA6 SH3BP4 NEO1 DST PI4KA BANP KIF14 PDZD8 SLC4A7 WDR7 EPB41L5 TRIOBP RAB11FIP1 ARFGEF3 CNNM3 EPB41L1 | 3.52e-05 | 442 | 298 | 19 | int:RHOQ |
| Interaction | KCNA3 interactions | ABL2 REPS1 SPTBN1 PSMC4 PTBP1 PRDM2 SPICE1 DST SEC16A PKHD1 KMT2A PDZD8 LRRC7 PRRC2A DNHD1 EPB41L5 FNDC3A PABPC1 ORC1 CCDC88C LMAN1 TLN1 GIGYF2 MACF1 IRS2 RIMS1 EIF4G3 ARHGEF26 EPB41L1 | 4.16e-05 | 871 | 298 | 29 | int:KCNA3 |
| Interaction | CAMSAP2 interactions | HDAC4 SPICE1 SRSF12 AMOT KIF14 CCDC22 GAS2L3 CREBBP GIGYF2 MACF1 SKA3 | 4.49e-05 | 169 | 298 | 11 | int:CAMSAP2 |
| Interaction | HDAC1 interactions | HDAC9 NR2C2 SP3 HIF1A MYCBP2 ZNF318 BIRC6 DST GSE1 ZNF608 AMOT BANP KIF14 KMT2A SAP130 SOX6 ADRM1 ZNF521 ARFGEF1 HBP1 SALL4 RFX1 CREBBP ARAF LRCH3 LMAN1 RABEP1 TLN1 GIGYF2 IRS2 SKA3 CROCC ZMYM3 HR | 4.63e-05 | 1108 | 298 | 34 | int:HDAC1 |
| Interaction | RAB35 interactions | DENND4A VPS13C SPTBN1 ITGA6 SPICE1 SH3BP4 DST MAVS AMOT PI4KA KIF14 PDZD8 SLC4A7 WDR7 EPB41L5 RAB11FIP1 FAS ARFGEF3 CNNM3 LMAN1 MACF1 EPB41L1 | 4.74e-05 | 573 | 298 | 22 | int:RAB35 |
| Interaction | EGR2 interactions | NCOA6 NR2C2 HDAC4 BCORL1 ZNF462 ZNF608 SEC16A KMT2A ZNF521 INO80 CREBBP | 4.99e-05 | 171 | 298 | 11 | int:EGR2 |
| Interaction | NUP43 interactions | NCOA6 NR2C2 CDK12 ZNF318 PRDM2 RTF1 ZNF462 DST GSE1 MAVS ZNF608 SUPT6H PI4KA KMT2A DDX31 INO80 KLC4 RIF1 ZNF532 ZFP91 EIF4G3 SRRM2 ZMYM3 | 6.09e-05 | 625 | 298 | 23 | int:NUP43 |
| Interaction | RYK interactions | EPHB3 KIAA0319L NEO1 DST PCDH18 SDK2 PCDHGA6 FAT3 IGDCC4 CNNM3 CSPG4 DCHS1 | 7.93e-05 | 212 | 298 | 12 | int:RYK |
| Interaction | EZR interactions | REPS1 HDAC4 JMY DST PI4KA SEC16A KIF14 PDZD8 DYNC1I2 SLC4A7 EPB41L5 TRIOBP KLC4 FAS RABEP1 FBXO43 MACF1 IRS2 EIF4G3 CROCC EPB41L1 | 8.24e-05 | 553 | 298 | 21 | int:EZR |
| Interaction | SLC6A4 interactions | REPS1 VPS13C NFASC SYNPO NLGN3 AMOT STARD9 LRRC7 FRMPD1 GRIA1 PABPC1 ARAF ELFN1 VCAN MACF1 REPS2 TNR EPB41L1 | 9.72e-05 | 437 | 298 | 18 | int:SLC6A4 |
| Interaction | SUMO1 interactions | HDAC9 SP3 HIF1A HDAC4 KIF14 PRRC2A SOX6 FAS ATF2 PABPC1 CREBBP TOPORS ZMYM3 TP53BP1 | 1.02e-04 | 287 | 298 | 14 | int:SUMO1 |
| Interaction | EIF3I interactions | NES NR2C2 RIN3 CDK12 PSMC4 KIF14 PDZD8 FAS LMAN1 SKA3 EIF4G3 SRRM2 EPB41L1 | 1.31e-04 | 258 | 298 | 13 | int:EIF3I |
| Interaction | PCDHGA10 interactions | 1.52e-04 | 19 | 298 | 4 | int:PCDHGA10 | |
| Interaction | TGM1 interactions | RIN3 TRPC4AP PI4KA IFI30 NELFA RFX1 CREBBP CNNM3 RBM12 TLN1 GIGYF2 EIF4G3 | 1.58e-04 | 228 | 298 | 12 | int:TGM1 |
| Cytoband | 5q31 | MYOT PCDHGC5 PCDHGA6 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 PCDHGA8 | 8.75e-08 | 115 | 306 | 9 | 5q31 |
| Cytoband | 19q13.2 | 1.58e-05 | 164 | 306 | 8 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | MYOT PCDHGC5 PCDHGA6 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 PCDHGA8 | 1.95e-04 | 298 | 306 | 9 | chr5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 4.81e-04 | 147 | 306 | 6 | chr15q15 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.13e-09 | 11 | 214 | 6 | 1315 | |
| GeneFamily | Fibronectin type III domain containing | EPHB3 NFASC DSCAML1 ANOS1 NEO1 FLRT3 SDK2 NRCAM FNDC3A IGDCC4 IGF1R ELFN1 TNR MYBPC2 | 6.96e-09 | 160 | 214 | 14 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | NFASC DSCAML1 LRIG2 NEO1 MYPN KAZALD1 SDK2 MYOT NRCAM IGDCC4 MDGA1 CEACAM20 MYBPC2 | 6.36e-08 | 161 | 214 | 13 | 593 |
| GeneFamily | Clustered protocadherins | PCDHGC5 PCDHGA6 PCDHB7 PCDHAC1 PCDHA11 PCDHA10 PCDHA2 PCDHGA8 | 8.47e-07 | 64 | 214 | 8 | 20 |
| GeneFamily | Immunoglobulin like domain containing | CEACAM6 DSCAML1 CEACAM1 NEO1 SDK2 NRCAM IGDCC4 LY9 MDGA1 CEACAM20 | 1.04e-04 | 193 | 214 | 10 | 594 |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.43e-04 | 163 | 214 | 9 | 590 | |
| GeneFamily | Histone deacetylases, class IIA | 8.24e-04 | 4 | 214 | 2 | 992 | |
| GeneFamily | Cadherin related | 9.84e-04 | 17 | 214 | 3 | 24 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 2.75e-03 | 24 | 214 | 3 | 906 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.82e-03 | 7 | 214 | 2 | 1113 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.87e-03 | 50 | 214 | 4 | 1293 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 3.73e-03 | 8 | 214 | 2 | 419 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.73e-03 | 8 | 214 | 2 | 939 | |
| GeneFamily | Regulatory factor X family | 3.73e-03 | 8 | 214 | 2 | 1153 | |
| GeneFamily | BEN domain containing | 4.75e-03 | 9 | 214 | 2 | 422 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 4.75e-03 | 9 | 214 | 2 | 1230 | |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 4.75e-03 | 9 | 214 | 2 | 435 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.79e-10 | 48 | 306 | 10 | MM531 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 7.23e-08 | 32 | 306 | 7 | MM2 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | HDAC9 MYCBP2 MAP6 VPS13C MGAT4A NFASC ZNF318 ZCCHC14 NEO1 DST GSE1 PTPRN IER3 PI4KA NR0B1 PDZD8 FNIP2 SLC4A7 NRCAM WDR7 SYBU RAB11FIP1 PREPL IGF1R LMAN1 RABEP1 RAB3IP GIGYF2 IRS2 EIF4G3 KAT6B EPB41L1 | 8.16e-08 | 946 | 306 | 32 | M39169 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.40e-07 | 35 | 306 | 7 | MM757 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | NCOA6 NR2C2 ABL2 PSG1 PSG4 PSG6 PSG7 PSG9 LRIG2 ZCCHC14 DST GSE1 IER3 PKD1 DMTF1 PLXNA3 SLC4A7 GDF15 BSDC1 HBP1 RAB11FIP1 ATF2 CREBBP IGF1R RABEP1 PCNX1 IRS2 TOPORS | 4.81e-07 | 822 | 306 | 28 | M6782 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 8.28e-07 | 87 | 306 | 9 | MM851 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | TRPC4AP PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 JMY CEACAM1 DDR2 FNDC3A | 2.87e-06 | 159 | 306 | 11 | MM760 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 HIF1A HDAC4 MYCBP2 ITGA6 ME2 DST GSE1 IER3 KIF14 DMD CHST3 SLC4A7 RASA1 WDR7 DDR2 ARFGEF1 FNDC3A ATF2 CREBBP RIF1 IGF1R GIGYF2 MACF1 EIF4G3 KAT6B TP53BP1 | 3.30e-06 | 856 | 306 | 27 | M4500 |
| Coexpression | GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP | GGA2 ANKRD40 CASS4 DMTF1 GAS2L3 TMEM132E ELFN1 JCHAIN RAB3IP LY9 SLAMF7 MYBPC2 | 4.26e-06 | 199 | 306 | 12 | M7486 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | PSG1 PSG3 PSG4 PSG6 PSG9 STARD10 CEACAM6 CEACAM1 EPB41L5 CDH3 | 4.42e-06 | 135 | 306 | 10 | MM965 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SP3 ZNF318 ZCCHC14 FAT2 DST GSE1 KIF14 DMTF1 BIRC2 FNDC3A ATF2 CREBBP RIF1 KAT6B | 1.32e-05 | 300 | 306 | 14 | M8702 |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.36e-05 | 93 | 306 | 8 | M40279 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | C5orf22 PSG1 PSG3 PSG4 PSG6 PSG9 STARD10 KIAA0319L CEACAM6 CEACAM1 TMEM139 TMEM158 NHLRC3 RAB11FIP1 RFX1 ARFGEF3 RAB3IP | 1.68e-05 | 436 | 306 | 17 | MM1326 |
| Coexpression | GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN | PSG1 SPTBN1 SNRK SPTBN5 SEC16A MPO ADRM1 SPATA31C2 FAS TOPORS RUBCN | 2.30e-05 | 198 | 306 | 11 | M7701 |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 2.67e-05 | 102 | 306 | 8 | M10290 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.78e-05 | 75 | 306 | 7 | MM605 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | TCERG1L HDAC4 SLCO2B1 STARD9 PI4KA NR0B1 PCDH18 REC8 GAS2L3 DDR2 ZNF521 GRIA1 ADAMTS8 IGDCC4 TMEM132E CROCC | 3.04e-05 | 411 | 306 | 16 | M1351 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SP3 DENND4A GGA2 MYCBP2 VPS13C MGAT4A SNRK BIRC6 JMY PRDM2 MS4A2 NBEAL2 KMT2A TSC22D4 PDLIM2 C16orf54 DMTF1 VMA21 SLC4A7 RASA1 XPO4 BIRC2 FAS ATF2 CREBBP SCML4 CCDC88C RIF1 RBM12 TLN1 JCHAIN MACF1 PCNX1 LY9 SLAMF7 KAT6B | 3.12e-05 | 1492 | 306 | 36 | M40023 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | PSG1 PSG3 PSG4 PSG6 PSG9 STARD10 CEACAM6 SYNPO CEACAM1 PDLIM2 TMEM158 NHSL1 VCAN | 3.29e-05 | 284 | 306 | 13 | MM987 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | TCERG1L HDAC4 SLCO2B1 STARD9 PI4KA NR0B1 PCDH18 REC8 GAS2L3 DDR2 ZNF521 GRIA1 ADAMTS8 IGDCC4 TMEM132E CROCC | 3.51e-05 | 416 | 306 | 16 | MM1002 |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | ABCA2 RTF1 NEO1 KMT2A NID1 WDR90 ATG9A FAM174C PLXNA3 RAB11FIP1 ATF2 IGDCC4 AASS TLN1 DCHS1 MACF1 IRS2 INS-IGF2 HR | 3.97e-05 | 563 | 306 | 19 | M15103 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | HDAC9 ABCA2 MAP6 SPTBN1 NFASC SYNPO ABCA7 DSCAML1 SH3BP4 NLGN3 NEO1 DST PDLIM2 PLXNA3 TMEM150A NRCAM HBP1 ATP13A2 E2F8 NHSL1 RBM12 LMAN1 PCNX1 TMEM108 REPS2 TNR RUBCN EPB41L1 HR | 4.27e-05 | 1102 | 306 | 29 | M2369 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | HDAC9 PSG3 PSG4 PSG6 PSG9 ITGA6 CEACAM6 CEACAM1 FLRT3 FNIP2 PLXNA3 SDK2 NRCAM GDF15 PCDHB7 EPB41L5 ARFGEF3 IGF1R RABEP1 MACF1 GREB1 SRRM2 EPB41L1 | 5.71e-05 | 786 | 306 | 23 | M10961 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | HDAC9 ABCA2 MAP6 SPTBN1 NFASC SYNPO ABCA7 DSCAML1 SH3BP4 NLGN3 NEO1 DST PDLIM2 PLXNA3 TMEM150A NRCAM HBP1 ATP13A2 E2F8 NHSL1 RBM12 LMAN1 PCNX1 TMEM108 REPS2 TNR RUBCN EPB41L1 HR | 6.06e-05 | 1124 | 306 | 29 | MM1070 |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 6.50e-05 | 184 | 306 | 10 | M19988 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | ABCA2 MAP6 SPTBN1 STARD10 NFASC CSMD2 NEO1 PKD1 LRRC7 CACNA1A SDK2 FAT3 SYBU PREPL GUCY1A2 IRS2 MDGA1 | 6.88e-05 | 488 | 306 | 17 | M39104 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 CEACAM1 PI16 NFE2L3 JCHAIN CSPG4 | 8.96e-05 | 230 | 306 | 11 | MM986 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 1.05e-04 | 195 | 306 | 10 | M4195 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TCERG1L MYCBP2 MAP6 NFASC ZNF318 CSMD2 DSCAML1 PRDM2 SRSF12 ZNF462 HSPA12A FAT2 GSE1 LRRC7 CACNA1A PLXNA3 ANK1 ARFGEF1 GRIA1 SALL4 SYBU PREPL ARFGEF3 WDR97 VCAN RIMS1 MDGA1 EPB41L1 | 1.12e-04 | 1106 | 306 | 28 | M39071 |
| Coexpression | GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN | 1.19e-04 | 198 | 306 | 10 | M3325 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | CEACAM6 ZNF318 FHIP1B JMY PRDM2 C16orf54 TMEM150A ANK1 LRCH3 LY9 | 1.30e-04 | 200 | 306 | 10 | M8618 |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN | 1.30e-04 | 200 | 306 | 10 | M3914 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN | CDK12 SMYD4 NEO1 IER3 RPS6KA6 KAZALD1 WDR90 ATG9A DDX31 NRCAM | 1.30e-04 | 200 | 306 | 10 | M6201 |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP | HIF1A GGA2 B4GALNT1 MAN2C1 ZNF318 PLXNA3 RASA1 TMEM158 IGF1R TP53BP1 | 1.30e-04 | 200 | 306 | 10 | M6352 |
| Coexpression | GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN | DENND4A ABL2 ITGA6 ME2 SRSF12 BRDT REV1 RAB3IP MAPKBP1 EPB41L1 | 1.30e-04 | 200 | 306 | 10 | M6574 |
| Coexpression | GSE22886_DC_VS_MONOCYTE_DN | RIN3 MYCBP2 NBEAL2 ATP13A2 CREBBP CCDC88C CNNM3 IGF1R VCAN IRS2 | 1.30e-04 | 200 | 306 | 10 | M4472 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.34e-04 | 128 | 306 | 8 | MM1000 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | HDAC9 ITGA6 CEACAM6 CEACAM1 FAT2 DST IER3 NBEAL2 IFI30 FLRT3 DMD ARHGAP8 NRCAM SYBU NFE2L3 CDH3 | 1.57e-04 | 473 | 306 | 16 | M4306 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | ABCA2 PSG1 PSG3 PSG4 PSG6 PSG9 SPTBN1 CEACAM6 CEACAM1 MGAT2 IER3 DMD HBP1 ATF2 MSRA NHSL1 LMAN1 NKD2 CDH3 SOD3 HR | 1.86e-04 | 741 | 306 | 21 | MM1037 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | SPTBN1 CEACAM6 ABCA7 ANOS1 DST NBEAL2 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 FAS RANBP17 NHSL1 ARHGEF26 | 2.26e-04 | 391 | 306 | 14 | M41659 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | ATP5MC1 HDAC9 SP3 DENND4A SYNPO ZNF462 NLGN3 NEO1 FAT2 DST STARD9 RPS6KA6 FLRT3 PCDH18 DYNC1I2 SLC4A7 DDX31 RASA1 GAS2L3 DDR2 FRMPD1 ZNF521 PCDHA11 SALL4 RFWD3 RIF1 NKD2 VCAN GIGYF2 RIMS1 KAT6B | 1.10e-06 | 850 | 296 | 31 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | ATP5MC1 HDAC9 BNC2 SP3 DENND4A NLGN3 NEO1 MGAT2 RPS6KA6 PDZD8 FLRT3 DYNC1I2 DDX31 RASA1 GAS2L3 DDR2 ZNF521 PCDHA11 RIF1 VCAN GIGYF2 | 6.28e-06 | 492 | 296 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | BNC2 NR2C2 SP3 ABL2 SPTBN1 ITGA6 SYNPO BIRC6 ME2 BRDT NR0B1 NID1 KAZALD1 SHCBP1L TAF4B VMA21 MYOT GAS2L3 PIWIL4 HBP1 SALL4 SYBU RNF17 CREBBP RIF1 RIMS1 GREB1 | 1.15e-05 | 770 | 296 | 27 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | ATP5MC1 HDAC9 BNC2 SP3 DENND4A ZNF462 NLGN3 NEO1 MGAT2 DST RPS6KA6 PDZD8 FLRT3 PCDH18 DYNC1I2 DDX31 RASA1 GAS2L3 FAT3 DDR2 ZNF521 PCDHA11 SALL4 RIF1 VCAN ZFP91 GIGYF2 KAT6B | 1.81e-05 | 836 | 296 | 28 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3 | HDAC9 DENND4A GGA2 B4GALNT1 ZNF318 CEACAM1 ZNF608 IFI30 KMT2A NID1 CHST3 SLC4A7 WDFY4 SCML4 MACF1 RUBCN | 3.83e-05 | 352 | 296 | 16 | GSM538198_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | HDAC9 SP3 DENND4A NLGN3 NEO1 STARD9 RPS6KA6 FLRT3 DYNC1I2 SLC4A7 DDX31 RASA1 GAS2L3 DDR2 PCDHA11 RFWD3 RIF1 VCAN GIGYF2 | 4.60e-05 | 478 | 296 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | BNC2 NR2C2 SP3 GGA2 ABL2 SPTBN1 BCORL1 KDM5D FHIP1B BIRC6 ZNF462 ZCCHC14 STARD9 PKHD1 NID1 GAS2L3 ZNF618 FAT3 XPO4 FNDC3A ATF2 CREBBP RIF1 LMAN1 GIGYF2 TOPORS | 6.13e-05 | 801 | 296 | 26 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | ABCA2 GGA2 REPS1 VPS13C SPICE1 LRIG2 GSE1 ZNF608 TRPM3 PKD1 RPS6KA6 WDR90 PCDH18 SDK2 CCDC22 DDX31 NRCAM ZNF618 FAT3 ZNF521 TRIOBP IPO4 PREPL CCDC88C IGF1R LMAN1 ZNF532 ELFN1 AASS GREB1 KAT6B ARHGEF26 SRRM2 CDH3 ZMYM3 | 6.35e-05 | 1245 | 296 | 35 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | ATP5MC1 HDAC9 C5orf22 CDK12 MGAT4A ITGA6 SYNPO ZNF462 ZCCHC14 DST FLRT3 PCDH18 DDR2 PCDHB7 ZNF521 PCDHA11 SALL4 NFE2L3 RIF1 NKD2 VCAN ZFP91 GIGYF2 RIMS1 KAT6B | 8.32e-05 | 769 | 296 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.03e-04 | 54 | 296 | 6 | gudmap_developingGonad_P2_ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | ATP5MC1 ZNF462 NLGN3 NEO1 FAT2 DST RPS6KA6 FLRT3 GAS2L3 DDR2 ZNF521 PCDHA11 SALL4 RIF1 NKD2 GIGYF2 RIMS1 | 1.16e-04 | 428 | 296 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#2_top-relative-expression-ranked_500 | 1.17e-04 | 79 | 296 | 7 | gudmap_developingGonad_e14.5_ testes_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | SP3 ITGA6 KDM5D ME2 ZNF462 NEO1 DST NR0B1 PCDH18 SOX6 TMEM150A ADRM1 ZNF618 FAT3 FRMPD1 BIRC2 IGDCC4 ORC1 NHSL1 NKD2 ZNF532 ELFN1 VCAN CDH3 ZMYM3 EPB41L1 | 1.25e-04 | 837 | 296 | 26 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.26e-04 | 136 | 296 | 9 | gudmap_developingGonad_e14.5_ testes_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | CDK12 ZNF462 ZCCHC14 DST DDR2 PCDHB7 ZNF521 PCDHA11 SALL4 RIF1 NKD2 VCAN ZFP91 GIGYF2 RIMS1 KAT6B | 1.28e-04 | 390 | 296 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | BNC2 ITGA6 ME2 LRIG2 NEO1 AMOT NR0B1 RPS6KA6 FLRT3 PCDH18 SOX6 NACC1 ZNF618 FAT3 ZNF521 IGDCC4 ORC1 GUCY1A2 ELFN1 VCAN TMEM108 REPS2 KAT6B CDH3 EPB41L1 | 1.45e-04 | 797 | 296 | 25 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NES SP3 ABCA2 MAP6 SLCO2B1 DSCAML1 ZNF462 PKHD1 RPS6KA6 KIF14 DMD MPO SOX6 CACNA1A SMAP1 SLC4A7 NRCAM RASA1 HCN4 ZNF618 FAT3 EPB41L5 SALL4 E2F8 LRCH3 RANBP17 ORC1 CCDC88C RIF1 GUCY1A2 RABEP1 MACF1 CFAP74 GREB1 MDGA1 TP53BP1 SOD3 | 1.67e-04 | 1414 | 296 | 37 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | BNC2 NR2C2 SP3 HIF1A ABL2 SPTBN1 ZNF318 KDM5D BIRC6 ZNF462 ZCCHC14 BRDT NR0B1 TAF4B SOX6 SLC4A7 GAS2L3 ZNF618 XPO4 SALL4 SYBU RNF17 CREBBP RIF1 TOPORS | 1.73e-04 | 806 | 296 | 25 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | B cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3 | HDAC9 DENND4A GGA2 ZNF318 CEACAM1 ZNF608 IFI30 NID1 CHST3 SLC4A7 WDFY4 SCML4 JCHAIN MACF1 RUBCN | 2.15e-04 | 367 | 296 | 15 | GSM399440_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | BNC2 NR2C2 ABL2 ZNF318 ZCCHC14 HSPA12A BRDT NR0B1 NID1 KAZALD1 SHCBP1L TAF4B PRRC2A PCDH18 PLXNA3 NELFA EPB41L5 PIWIL4 HBP1 SALL4 RNF17 RIF1 LMAN1 TOPORS ZMYM3 | 2.33e-04 | 822 | 296 | 25 | gudmap_developingGonad_e14.5_ testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | HDAC9 BNC2 NR2C2 SP3 HIF1A ABL2 CDK12 SPTBN1 ITGA6 ZNF318 BIRC6 ME2 BRDT NR0B1 RPS6KA6 TAF4B REC8 SALL4 SYBU RNF17 ARAF RIF1 GIGYF2 GREB1 | 2.43e-04 | 776 | 296 | 24 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 2.47e-04 | 89 | 296 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | BNC2 NR2C2 SP3 GGA2 ABL2 CDK12 SPTBN1 BCORL1 FHIP1B BIRC6 ZNF462 STARD9 NID1 SDK2 GAS2L3 ZNF618 FAT3 XPO4 CREBBP RIF1 LMAN1 TLN1 GIGYF2 TOPORS | 3.15e-04 | 790 | 296 | 24 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | BNC2 SP3 ITGA6 ME2 ZNF462 LRIG2 NEO1 DST STARD9 NR0B1 PCDH18 REC8 ZNF618 FRMPD1 EPB41L5 ARFGEF1 BIRC2 IGDCC4 ORC1 GUCY1A2 ELFN1 KAT6B ZMYM3 EPB41L1 | 3.21e-04 | 791 | 296 | 24 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 NFASC DST NID1 CASS4 SDK2 FAT3 DDR2 GRIA1 ADAMTS8 NKD2 AASS MACF1 TMEM108 | 7.97e-11 | 193 | 306 | 14 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 LRRC7 SDK2 NRCAM FAT3 DDR2 GRIA1 ADAMTS8 NAALADL2 IGDCC4 NKD2 GUCY1A2 TMEM108 | 1.01e-09 | 194 | 306 | 13 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 VPS13C KDM5D DST PTPRN SEC16A KMT2A CACNA1A SLC4A7 ARFGEF1 RIF1 MACF1 SRRM2 | 1.08e-09 | 195 | 306 | 13 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 VPS13C KDM5D DST PTPRN SEC16A KMT2A CACNA1A SLC4A7 ARFGEF1 RIF1 MACF1 SRRM2 | 1.08e-09 | 195 | 306 | 13 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 TMEM139 EPB41L5 RAB11FIP1 RANBP17 REPS2 ARHGEF26 | 1.15e-09 | 196 | 306 | 13 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 TMEM139 EPB41L5 RAB11FIP1 RANBP17 REPS2 ARHGEF26 | 1.15e-09 | 196 | 306 | 13 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | HDAC9 SPTBN1 CEACAM6 ABCA7 ANOS1 NBEAL2 FLRT3 TMEM139 EPB41L5 RAB11FIP1 REPS2 ARHGEF26 | 4.74e-09 | 180 | 306 | 12 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 TMEM139 EPB41L5 RANBP17 REPS2 ARHGEF26 | 9.81e-09 | 192 | 306 | 12 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 ACSS3 SDK2 NRCAM FAT3 DDR2 ADAMTS8 IGDCC4 NKD2 GUCY1A2 TMEM108 SOD3 | 9.81e-09 | 192 | 306 | 12 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 ACSS3 SDK2 NRCAM FAT3 DDR2 GRIA1 ADAMTS8 IGDCC4 GUCY1A2 TMEM108 SOD3 | 1.10e-08 | 194 | 306 | 12 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 NBEAL2 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 1.17e-08 | 195 | 306 | 12 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 NBEAL2 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 1.17e-08 | 195 | 306 | 12 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | NES BNC2 KCNJ13 NID1 PCDH18 NRCAM TMEM158 ZNF521 GUCY1A2 DCHS1 SOD3 | 5.74e-08 | 182 | 306 | 11 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | CEACAM6 SYNPO ABCA7 NLGN3 ANOS1 DST NBEAL2 PDLIM2 RAB11FIP1 MDGA1 ARHGEF26 | 6.42e-08 | 184 | 306 | 11 | c7073d1b2c4fdb154d87678b92a0629c02116972 |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | CEACAM6 SYNPO ABCA7 NLGN3 ANOS1 DST NBEAL2 PDLIM2 RAB11FIP1 MDGA1 ARHGEF26 | 6.42e-08 | 184 | 306 | 11 | 1ed558a88215b248431c524ea16f13d9022ae98c |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CEACAM6 ABCA7 ANOS1 DST FLRT3 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 6.42e-08 | 184 | 306 | 11 | ca940a4f4970285ed284d5517d142abab0682044 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 ACSS3 SDK2 NRCAM FAT3 DDR2 ADAMTS8 IGDCC4 GUCY1A2 VCAN SOD3 | 9.39e-08 | 191 | 306 | 11 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 PDLIM2 RAB11FIP1 RANBP17 ARHGEF26 | 9.39e-08 | 191 | 306 | 11 | 3457e15d1e9b36a78363d46b320c4ec46b40290a |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 DST NID1 CASS4 FAT3 GRIA1 ADAMTS8 NKD2 AASS MACF1 TMEM108 | 1.04e-07 | 193 | 306 | 11 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 DST NID1 CASS4 FAT3 GRIA1 ADAMTS8 NKD2 AASS TMEM108 IRS2 | 1.10e-07 | 194 | 306 | 11 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | BNC2 NFASC DST NID1 CASS4 FAT3 DDR2 GRIA1 ADAMTS8 NKD2 TMEM108 | 1.16e-07 | 195 | 306 | 11 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.16e-07 | 195 | 306 | 11 | 792d6a49b0a875a00569071183d195287a9925c5 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 NBEAL2 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.22e-07 | 196 | 306 | 11 | eb68f7954e7c2f86d05e740e95b6e74805a6053f |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | CEACAM6 SYNPO ABCA7 ANOS1 DST FLRT3 TMEM139 EPB41L5 RAB11FIP1 MDGA1 ARHGEF26 | 1.22e-07 | 196 | 306 | 11 | 150554fa06868d29b0608189862eef6505ba757f |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPTBN1 CEACAM6 ABCA7 ANOS1 DST FLRT3 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.28e-07 | 197 | 306 | 11 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPTBN1 CEACAM6 ABCA7 ANOS1 DST FLRT3 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.28e-07 | 197 | 306 | 11 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPTBN1 CEACAM6 ABCA7 ANOS1 DST FLRT3 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.28e-07 | 197 | 306 | 11 | c9c968e223e7814cd8d22975d849a31b7e0af7aa |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | SPTBN1 CEACAM6 SYNPO ABCA7 ANOS1 DST PDLIM2 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.28e-07 | 197 | 306 | 11 | 7d19b93d6853828e2a036e37c4887edb1de4503c |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | BNC2 NEO1 GSE1 CASS4 SDK2 ZNF521 NAALADL2 NKD2 VCAN MACF1 TMEM108 | 1.28e-07 | 197 | 306 | 11 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | CEACAM6 ABCA7 ANOS1 DST FLRT3 TMEM139 ASPG EPB41L5 RANBP17 ARHGEF26 MUC3A | 1.35e-07 | 198 | 306 | 11 | 75bdecbe111fededf6082b11de18b84ca308ef6d |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-07 | 199 | 306 | 11 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | NFASC DST NID1 CASS4 SDK2 FAT3 GRIA1 ADAMTS8 NKD2 AASS MACF1 | 1.50e-07 | 200 | 306 | 11 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CEACAM6 ABCA7 ANOS1 NBEAL2 FLRT3 TMEM139 EPB41L5 RAB11FIP1 RANBP17 REPS2 ARHGEF26 | 1.50e-07 | 200 | 306 | 11 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | NFASC DST NID1 CASS4 SDK2 FAT3 GRIA1 ADAMTS8 NKD2 AASS MACF1 | 1.50e-07 | 200 | 306 | 11 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-07 | 200 | 306 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | CEACAM6 SYNPO ABCA7 ANOS1 NBEAL2 FLRT3 TMEM139 EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 1.50e-07 | 200 | 306 | 11 | 5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67 |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CEACAM6 SYNPO ABCA7 ANOS1 NBEAL2 FLRT3 TMEM139 EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 1.50e-07 | 200 | 306 | 11 | c6f211bbadd0c9be776c58807249e06764df47dc |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-07 | 200 | 306 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | CEACAM6 SYNPO ABCA7 ANOS1 NBEAL2 FLRT3 TMEM139 EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 1.50e-07 | 200 | 306 | 11 | e3a80626941363bfc9d97ef906d38c97080aecb1 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NFASC DST NID1 CASS4 SDK2 FAT3 GRIA1 ADAMTS8 NKD2 AASS MACF1 | 1.50e-07 | 200 | 306 | 11 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CEACAM6 ABCA7 ANOS1 NBEAL2 FLRT3 TMEM139 EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 2.82e-07 | 169 | 306 | 10 | cd16e8462ee09877be962fbd9a3badcb825820b0 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DENND4A VPS13C ITGAD TRPM3 REC8 SDK2 SLC4A7 HCN4 RPUSD1 PCNX1 | 3.69e-07 | 174 | 306 | 10 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | NES SPTBN1 ITGA6 SYNPO ZNF318 SPTBN5 PTPRN NRCAM PCDHA10 ELFN1 | 4.32e-07 | 177 | 306 | 10 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SLCO2B1 DSCAML1 ANOS1 TRPM3 NBEAL2 PKHD1 FLRT3 SOX6 EPB41L5 ARHGEF26 | 4.32e-07 | 177 | 306 | 10 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | SPTBN1 CEACAM6 ERVW-1 ABCA7 ANOS1 NBEAL2 FLRT3 TMEM139 ARHGEF26 CDH3 | 4.79e-07 | 179 | 306 | 10 | d5763912a4ce7188535675e338799b856edb9dda |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | CEACAM6 SYNPO ANOS1 DST TMEM139 EPB41L5 RANBP17 SLC7A4 MDGA1 ARHGEF26 | 4.79e-07 | 179 | 306 | 10 | 1603117b52623663458a977c94bf7f9f6c1114b8 |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-07 | 180 | 306 | 10 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | SPTBN1 CEACAM6 ABCA7 ANOS1 FLRT3 PDLIM2 TMEM139 RAB11FIP1 RANBP17 ARHGEF26 | 5.04e-07 | 180 | 306 | 10 | ff4728782c3ec814ba071cc22b7894abdd9da837 |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | CEACAM6 ABCA7 ANOS1 TMEM139 EPB41L5 SYBU RANBP17 REPS2 ARHGEF26 SOD3 | 5.30e-07 | 181 | 306 | 10 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-07 | 181 | 306 | 10 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-07 | 181 | 306 | 10 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | NES NFASC NID1 PCDH18 NRCAM TMEM158 DDR2 GUCY1A2 CSPG4 MUC3A | 5.87e-07 | 183 | 306 | 10 | 4617b18da8d699a44e4c47980197b1e7eb951470 |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 TMEM139 RAB11FIP1 MDGA1 ARHGEF26 | 6.17e-07 | 184 | 306 | 10 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 TMEM139 RAB11FIP1 MDGA1 ARHGEF26 | 6.17e-07 | 184 | 306 | 10 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | SPTBN1 ANOS1 DST NBEAL2 DMD EPB41L5 RAB11FIP1 RANBP17 REPS2 ARHGEF26 | 6.17e-07 | 184 | 306 | 10 | 561592edc3083fad41b91811151b442207c65dd9 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.15e-07 | 187 | 306 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | CEACAM6 SYNPO ANOS1 DST NBEAL2 PDLIM2 EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 7.88e-07 | 189 | 306 | 10 | 14e8e57e4db336fbef005270647983b4edf407c0 |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | CEACAM6 ZNF608 FLRT3 GDF15 EPB41L5 SYBU ARFGEF3 RANBP17 TMEM108 RIMS1 | 7.88e-07 | 189 | 306 | 10 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.67e-07 | 191 | 306 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | KIAA0319L ZNF608 NBEAL2 PKHD1 FLRT3 ACSS3 EPB41L5 SYBU RAB11FIP1 RANBP17 | 9.09e-07 | 192 | 306 | 10 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.09e-07 | 192 | 306 | 10 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.09e-07 | 192 | 306 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 ACSS3 NRCAM FAT3 DDR2 GRIA1 ADAMTS8 IGDCC4 GUCY1A2 SOD3 | 9.09e-07 | 192 | 306 | 10 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.09e-07 | 192 | 306 | 10 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 9.53e-07 | 193 | 306 | 10 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.99e-07 | 194 | 306 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.05e-06 | 195 | 306 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.05e-06 | 195 | 306 | 10 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-06 | 196 | 306 | 10 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-06 | 196 | 306 | 10 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | B4GALNT1 NLGN3 HSPA12A STARD9 DMD CHST3 MYOT GAS2L3 ADAMTS8 ARHGEF26 | 1.15e-06 | 197 | 306 | 10 | e239caae24f40564a24ad909754f5436f767ccdb |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | CEACAM6 SYNPO ANOS1 DST NBEAL2 PDLIM2 TMEM139 RAB11FIP1 MDGA1 ARHGEF26 | 1.15e-06 | 197 | 306 | 10 | e6cbfa267eb2e05b441fd034786faae07bb0e081 |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | CEACAM6 ABCA7 ANOS1 DST NBEAL2 PDLIM2 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.15e-06 | 197 | 306 | 10 | 80d81be244c94c435accb643449b4ce6a3462c7f |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | SPTBN1 CEACAM6 SYNPO ANOS1 DST FLRT3 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.15e-06 | 197 | 306 | 10 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | CEACAM6 SYNPO ANOS1 DST NBEAL2 PDLIM2 TMEM139 RAB11FIP1 MDGA1 ARHGEF26 | 1.15e-06 | 197 | 306 | 10 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | BNC2 NFASC NID1 DDR2 ZNF521 GRIA1 ADAMTS8 NKD2 GUCY1A2 GREB1 | 1.20e-06 | 198 | 306 | 10 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-06 | 198 | 306 | 10 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | PRSS2 CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 TMEM139 RAB11FIP1 ARHGEF26 | 1.20e-06 | 198 | 306 | 10 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | SPTBN1 CEACAM6 SYNPO ANOS1 DST PDLIM2 TMEM139 EPB41L5 RAB11FIP1 ARHGEF26 | 1.20e-06 | 198 | 306 | 10 | 0047a9ef7684230ac5179efea94461480e90bdaf |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | CEACAM6 SYNPO ABCA7 ANOS1 DST NBEAL2 PDLIM2 RAB11FIP1 MDGA1 ARHGEF26 | 1.26e-06 | 199 | 306 | 10 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.26e-06 | 199 | 306 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | DSCAML1 ANOS1 TRPM3 NBEAL2 PKHD1 FLRT3 SOX6 EPB41L5 SALL4 ARHGEF26 | 1.26e-06 | 199 | 306 | 10 | d43c605a4ff221cf78d91678c15d2ad20f831c7f |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CEACAM6 ERVW-1 ANOS1 FLRT3 TMEM139 ASPG EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 1.26e-06 | 199 | 306 | 10 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | EPHB3 VPS13C DSCAML1 ANOS1 TRPM3 PKHD1 FLRT3 SOX6 SALL4 ARHGEF26 | 1.26e-06 | 199 | 306 | 10 | a270630626df614f8605abddb7dee7c4d74f6149 |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-06 | 199 | 306 | 10 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-06 | 155 | 306 | 9 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | DSCAML1 ANOS1 TRPM3 NBEAL2 PKHD1 FLRT3 SOX6 EPB41L5 SALL4 ARHGEF26 | 1.32e-06 | 200 | 306 | 10 | ddfb1f006365bf16203ee49f20200f68220cc288 |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT1|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | CEACAM6 ANOS1 DST FLRT3 TMEM139 ASPG EPB41L5 RAB11FIP1 RANBP17 ARHGEF26 | 1.32e-06 | 200 | 306 | 10 | 3a9633f5913f12b6865fc777c84f3f3ba795a78d |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SLCO2B1 SPTBN1 ITGA6 SNRK BIRC6 DST ZNF608 KMT2A ZNF521 MACF1 | 1.32e-06 | 200 | 306 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-06 | 200 | 306 | 10 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, condition lineage and cell class | 1.32e-06 | 200 | 306 | 10 | cd381644fd8b8674a017d267bfbb00f2668294ae | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 165 | 306 | 9 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-06 | 165 | 306 | 9 | ebd668e87e5961a124d1d6fc25d1f03e4af05cd4 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.19e-06 | 165 | 306 | 9 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.19e-06 | 165 | 306 | 9 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.19e-06 | 165 | 306 | 9 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.54e-06 | 168 | 306 | 9 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-06 | 169 | 306 | 9 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | STARD10 OTOP2 CEACAM6 DSCAML1 KCNH6 PKHD1 CACNA1A RAB11FIP1 ARFGEF3 | 2.80e-06 | 170 | 306 | 9 | 985c2d5962100fab0d95bee39f382ccbe799331e |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-06 | 170 | 306 | 9 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| Computational | Neighborhood of EGFR | 8.37e-07 | 32 | 182 | 7 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.60e-06 | 35 | 182 | 7 | GNF2_IGFBP1 | |
| Computational | Neighborhood of CDKN1C | 4.78e-06 | 27 | 182 | 6 | GNF2_CDKN1C | |
| Computational | Neighborhood of MMP11 | 5.81e-06 | 42 | 182 | 7 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.09e-05 | 46 | 182 | 7 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.67e-05 | 49 | 182 | 7 | GNF2_KISS1 | |
| Drug | AC1L1IPV | 8.04e-08 | 43 | 300 | 8 | CID000004683 | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A | EPHB3 ABL2 SPTBN1 KCNH6 GPR75 RPS6KA6 CASS4 GDF15 FAS CREBBP CCDC88C SRRM2 | 6.39e-06 | 184 | 300 | 12 | 4755_UP |
| Drug | Bvpam | 6.57e-06 | 21 | 300 | 5 | CID000125185 | |
| Drug | mono-(2-ethylhexyl)phthalate | RIN3 GGA2 KDM5D QRICH2 ABCA7 SPTBN5 DST IER3 NBEAL2 NR0B1 PKHD1 DMD HSD17B4 PDLIM2 MPO ANK1 NRCAM PIWIL4 RANBP17 IRS2 RIMS1 MDGA1 EPB41L1 MYBPC2 | 7.67e-06 | 658 | 300 | 24 | ctd:C016599 |
| Drug | pyrvinium pamoate; Down 200; 1.25uM; MCF7; HT_HG-U133A_EA | EPHB3 NES B4GALNT1 PSMC4 CEACAM6 NBEAL2 ARAF E2F8 RIF1 SUGP1 KAT6B ARHGEF26 | 8.86e-06 | 190 | 300 | 12 | 870_DN |
| Drug | Ikvav | 9.64e-06 | 38 | 300 | 6 | CID000131343 | |
| Drug | Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | KIAA0319L ITGA6 TAF4B TSC22D4 C14orf93 CCDC22 GDF15 SYBU LMAN1 SUGP1 IRS2 GREB1 | 9.85e-06 | 192 | 300 | 12 | 1696_UP |
| Drug | 5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA | GGA2 BCORL1 CEACAM6 ZNF318 HSPA12A KAZALD1 FLRT3 TAF4B FNDC3A FAS SUGP1 GREB1 | 1.09e-05 | 194 | 300 | 12 | 898_UP |
| Drug | Apramycin [37321-09-8]; Up 200; 7.4uM; HL60; HT_HG-U133A | SLCO2B1 CEACAM6 ABCA7 CHRNG REC8 NRCAM HCN4 MLXIP FAS ATP13A2 SRRM2 SOD3 | 1.21e-05 | 196 | 300 | 12 | 2914_UP |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; PC3; HT_HG-U133A | ABCA2 PSG1 SNRK PRDM2 CHRNG ZCCHC14 HSPA12A C14orf93 FRMPD1 FAS LY9 LILRA4 | 1.41e-05 | 199 | 300 | 12 | 5090_UP |
| Drug | Etoposide | HIF1A C5orf22 HDAC4 CEACAM1 NR0B1 KMT2A DMD MPO GDF15 BIRC2 HBP1 FAS ATF2 IGDCC4 IGF1R P2RX7 CGREF1 VCAN MACF1 IRS2 TP53BP1 | 3.80e-05 | 587 | 300 | 21 | ctd:D005047 |
| Drug | ZNS 114-666 | 4.32e-05 | 49 | 300 | 6 | CID000409441 | |
| Drug | fluorine atom | 4.32e-05 | 49 | 300 | 6 | CID005360525 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | ZCCHC14 KAZALD1 TSC22D4 C14orf93 ANK1 FRMPD1 HBP1 MLXIP FAS PCNX1 IRS2 | 4.90e-05 | 191 | 300 | 11 | 6959_UP |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | EPHB3 ABCA2 HDAC4 CEACAM6 SUPT6H PRRC2A ARFGEF1 ATP13A2 CCDC88C MAPKBP1 ARHGEF26 | 5.64e-05 | 194 | 300 | 11 | 7457_DN |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | KIAA0319L CEACAM1 SUPT6H KAZALD1 TAF4B FRMPD1 EPB41L5 FNDC3A PCNX1 MAPKBP1 HR | 5.91e-05 | 195 | 300 | 11 | 5330_UP |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A | RIN3 GGA2 B4GALNT1 MGAT4A KAZALD1 PRRC2A CHST3 CACNA1A C14orf93 IGF1R HR | 5.91e-05 | 195 | 300 | 11 | 6662_DN |
| Drug | Mikamycine | 6.14e-05 | 17 | 300 | 4 | CID011979535 | |
| Drug | DO 897/99; Up 200; 8.2uM; HL60; HG-U133A | RIN3 GGA2 BCORL1 CHRNG GSE1 SUPT6H ANKRD40 C14orf93 SLC7A4 IGF1R TLN1 | 6.19e-05 | 196 | 300 | 11 | 1728_UP |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | EPHB3 ABCA2 GGA2 BCORL1 ZNF318 LRIG2 PDLIM2 DDX31 CCDC88C ARHGEF26 SRRM2 | 6.48e-05 | 197 | 300 | 11 | 7171_DN |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | NR2C2 CEACAM6 ZNF318 RTF1 C14orf93 FAS CCDC88C CGREF1 RABEP1 SUGP1 EIF4G3 | 6.48e-05 | 197 | 300 | 11 | 3417_DN |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | HDAC4 ANOS1 GSE1 SUPT6H PRRC2A PDLIM2 CHST3 CCDC22 LMAN1 CGREF1 RABEP1 | 6.48e-05 | 197 | 300 | 11 | 6288_DN |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A | NES MAN2C1 SPTBN1 CEACAM6 ZNF318 TAF4B FAS GRSF1 CCDC88C RBM12 RABEP1 | 6.78e-05 | 198 | 300 | 11 | 5688_DN |
| Drug | flufenamic acid; Up 200; 10uM; MCF7; HG-U133A | HDAC9 KDM5D DLEC1 CHST3 CACNA1A ANK1 FNDC3A SLC13A3 RFX2 DCHS1 RIMS1 | 6.78e-05 | 198 | 300 | 11 | 316_UP |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; PC3; HT_HG-U133A | SUPT6H KCNJ13 KMT2A REC8 CASS4 ANK1 FRMPD1 P2RX7 SUGP1 LY9 CROCC | 6.78e-05 | 198 | 300 | 11 | 6702_UP |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | EPHB3 PRR4 GGA2 MAN2C1 SUPT6H CHST3 SYBU LMAN1 SUGP1 GREB1 EPB41L1 | 6.78e-05 | 198 | 300 | 11 | 6257_UP |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; HL60; HT_HG-U133A | EPHB3 PSG1 NFASC SPTBN5 TRPM3 NID1 DMD SYBU CSPG4 EPB41L1 HR | 6.78e-05 | 198 | 300 | 11 | 3051_UP |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | GGA2 RTF1 SUPT6H DDX31 NRCAM COQ6 ARFGEF1 ATP13A2 RABEP1 EIF4G3 KAT6B | 6.78e-05 | 198 | 300 | 11 | 6228_DN |
| Drug | Prostaglandin E1; Down 200; 10uM; MCF7; HT_HG-U133A | PRR4 PRDM2 RTF1 KAZALD1 TSC22D4 PDLIM2 SLC4A7 TMEM158 EPB41L5 RAB11FIP1 SRRM2 | 6.78e-05 | 198 | 300 | 11 | 6576_DN |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; HL60; HG-U133A | ABCA2 GGA2 ABL2 TRPM3 PDLIM2 XPO4 CNNM3 SLC7A4 SUGP1 LY9 SOD3 | 7.09e-05 | 199 | 300 | 11 | 1725_UP |
| Drug | (+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA | EPHB3 ABCA2 MYCBP2 BCORL1 KMT2A ATG9A CCDC22 DDX31 BSDC1 CCDC88C RBM12 | 7.09e-05 | 199 | 300 | 11 | 954_DN |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; HL60; HG-U133A | PRR4 GGA2 MGAT4A SNRK ZCCHC14 SUPT6H NBEAL2 TSC22D4 REC8 SUGP1 EIF4G3 | 7.42e-05 | 200 | 300 | 11 | 2011_UP |
| Disease | cortical thickness | HDAC9 BNC2 RIN3 B4GALNT1 PSG1 MYCBP2 SPTBN1 ZNF318 ME2 ZNF462 NEO1 PI4KA PKD1 PKHD1 KMT2A DLEC1 FNIP2 FAT3 TRIOBP SYBU ADAMTS8 ATP13A2 RAB44 MSRA NHSL1 IGF1R VCAN MACF1 TMEM108 EIF4G3 INS-IGF2 | 3.88e-07 | 1113 | 298 | 31 | EFO_0004840 |
| Disease | cD177 antigen measurement | 7.82e-07 | 18 | 298 | 5 | EFO_0021866 | |
| Disease | Malignant neoplasm of breast | NCOA6 HIF1A MAN2C1 HDAC4 SLCO2B1 BCORL1 ZNF318 ZCCHC14 LRRC7 DLEC1 DMD TSC22D4 PRRC2A ANK1 NRCAM FRMPD1 BIRC2 RFX2 ATF2 PABPC1 ARAF RIF1 IGF1R GUCY1A2 ZNF532 MACF1 REPS2 KAT6B TP53BP1 | 1.74e-06 | 1074 | 298 | 29 | C0006142 |
| Disease | MASA syndrome (implicated_via_orthology) | 3.46e-05 | 7 | 298 | 3 | DOID:0060246 (implicated_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 6.53e-05 | 68 | 298 | 6 | DOID:5419 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALPAVETQAPTSLAT | 256 | Q6UXB8 | |
| RAPDSLENVISNAVP | 141 | Q8N9N5 | |
| SSIALAAEDPVQPNA | 1256 | O00555 | |
| NRRANLALPQEPSSV | 6 | Q01362 | |
| RPAQDISLPLSARNS | 291 | Q4VCS5 | |
| LSSAPQELNPAVTAA | 1286 | Q9NYV4 | |
| TPLVALPTLATQAEA | 301 | P0C7U0 | |
| SSSPTAQPAEVLLQA | 3171 | Q9NR09 | |
| LSELERTNSTPPVAA | 2091 | Q7Z408 | |
| VPSSFLIPRVEQQNT | 331 | Q9NQ75 | |
| SSPEINPETQAALIR | 3006 | P13611 | |
| LQLSSPPARDVAATL | 1676 | Q6UVK1 | |
| ISRAQLSVVDPDSAP | 1851 | Q6UVK1 | |
| LSSALTEPVPNSQLV | 1096 | P42684 | |
| VTQIANPATAPEARV | 286 | Q9NW68 | |
| LSRSQSPADQLLIAP | 126 | Q00973 | |
| IIQSREPSLSNSNPD | 536 | Q58F21 | |
| TPNRNALTSITNVEP | 381 | Q6ZN30 | |
| QASELVVPTRLPGSA | 36 | Q9UP79 | |
| PLAPAAVQDTQSRLQ | 361 | P07510 | |
| VDNRPQAPLVSASAV | 1581 | Q9Y6D6 | |
| TRTAAVLLQNDPNPD | 186 | P16157 | |
| PQVVPSSLNLVENAR | 256 | Q6UY09 | |
| RDSPAVSLSEPATQQ | 911 | Q14687 | |
| QVSAAPAPRASVATD | 156 | Q9H116 | |
| SLVRNSLTAAPVNLP | 231 | Q9NZU0 | |
| ATQPLESQNFSPVVR | 431 | Q9UDR5 | |
| DSNPLSVSASVLVPV | 271 | Q5H9F3 | |
| LSQAAASIDNRVPTP | 961 | Q92793 | |
| NLGPQTVLEVPARST | 136 | Q6UWD8 | |
| LVPFRDLNPSSEVNT | 66 | Q96MU5 | |
| VSARQLPPSVARVDA | 326 | Q9Y2Z9 | |
| VPLAQTAQPTSAIVR | 151 | P15336 | |
| TAQPTSAIVRPASLQ | 156 | P15336 | |
| SAIVRPASLQVPNVL | 161 | P15336 | |
| PASLQVPNVLLTSSD | 166 | P15336 | |
| AAQIPAQVPTASDSR | 61 | Q96DR7 | |
| QNGDVSAPSAILRTP | 186 | Q6AI12 | |
| PNSASNRLLLTQPTE | 61 | A6NGH8 | |
| AQNPRRSVPLAIAIS | 261 | O43246 | |
| LLTESVNSVIAQAPP | 1216 | P11532 | |
| SQPRSPAQILISLES | 3486 | P11532 | |
| VPAESSASLPAVLTQ | 4211 | Q96M86 | |
| SLRQAGTAVPPDVQT | 11 | O60826 | |
| AANSPTTNPVILIVD | 106 | Q99674 | |
| ALLTLRNSAQAPPDS | 131 | Q5HYR2 | |
| VTLTAAAPASPEQII | 531 | Q9Y222 | |
| LIRPVSASFLNSPVN | 21 | P05496 | |
| TLTLRVPAARSQPAA | 2021 | Q8IZY2 | |
| VLAAPAITQAPEALS | 331 | Q8TDY8 | |
| LRPITQAPSETATDA | 581 | Q7Z401 | |
| ETANLDIPPANASRS | 91 | Q9NTZ6 | |
| FSELRASLINSQPLP | 1016 | Q9H2T7 | |
| QANREPDFSSLVSPL | 491 | O95072 | |
| PRIQIISTDSAVASP | 6 | P49116 | |
| NIISDSPSPIAARTL | 916 | P20936 | |
| PSALSSVPIQANALD | 61 | Q96QF0 | |
| LLVSLPSATPQAQVE | 716 | Q7Z6P3 | |
| VQQDLPLARDQPSSV | 196 | Q9H0J4 | |
| PASQPDVSLQQRVAE | 6 | Q15276 | |
| SILQPAPAEVISSQA | 51 | Q6PCD5 | |
| NDNRPEVIITSLFSP | 341 | Q9Y5G5 | |
| LVIVDDPASSAPQSR | 1381 | Q9ULG1 | |
| LLPQSLAAAAAVPTR | 101 | Q12849 | |
| SASNIVSPQEALPGR | 26 | Q9UJ68 | |
| AAAAAATPAVRTVPQ | 496 | P11940 | |
| NDNSPQFSRSLIPIE | 131 | Q9HCL0 | |
| SPAIISIRQEPTNSQ | 891 | Q9Y5H9 | |
| VRSVNSPSVPALENS | 1611 | Q8WYB5 | |
| QPSAAPLQVSRGLSA | 596 | Q9NSK0 | |
| VTRNDPELPAVTSSL | 386 | Q8NFP4 | |
| PSTPSRLALFLRQQS | 496 | Q8N612 | |
| PAPANLRLANSTVNS | 291 | P23352 | |
| VDPSLNPISAFRLSV | 501 | Q9UM21 | |
| VTSLSLPVREDAQPS | 351 | Q9Y5I1 | |
| TVLDVNDNPPVFTRA | 2591 | Q96JQ0 | |
| AQTRQASALIDRPAP | 401 | Q9H4G0 | |
| SNRPPIASLSQTEVV | 216 | Q15058 | |
| SPAVQPDAALQRLAA | 326 | Q16849 | |
| TIISLNVADTNDNPP | 436 | Q9Y5G7 | |
| IAGQISDRPSLSVQP | 316 | P59901 | |
| QNRVPAEPSSLLSLS | 441 | Q96II8 | |
| QVEAPASLTVLTPDQ | 261 | Q96I82 | |
| TVDVATALPLQVAPS | 31 | P56524 | |
| NAASLAPTPVSAVLE | 116 | P46695 | |
| NSEQALQTLSPRAIP | 156 | Q7Z434 | |
| ALAPPSARAVAIETQ | 56 | Q96JE9 | |
| AAARPAPREAQVSSV | 166 | Q8N9B5 | |
| PPSIASLLTAAVIDN | 26 | Q9H3P2 | |
| SIEASLRSNNLVPRP | 21 | Q4ZG55 | |
| RVSNVSAASLVPAVP | 66 | Q10469 | |
| AAVSNNIVVRPSRSP | 131 | Q92823 | |
| LSEDTLVLPPASRNQ | 56 | Q86U10 | |
| IPDNDLSNLPTTIAS | 76 | Q96NW7 | |
| PLVLDDVNPSARFVT | 321 | Q16832 | |
| AEEASPLRPAQVTLS | 26 | Q9BVV8 | |
| PRAALRPAVSSSDQQ | 166 | Q8IZA0 | |
| AASPTTIPVLDALAQ | 1636 | Q03001 | |
| PLRSSADPALNQEVA | 461 | Q16665 | |
| EIQNPASANRSDPVT | 216 | P40199 | |
| QAEAREALATLPSSP | 871 | Q9BY66 | |
| APASNDLALVPIASE | 866 | Q9H252 | |
| PTASISVEGNPALNR | 561 | Q13409 | |
| AASQPLRSQAENPDT | 1446 | Q9P219 | |
| QARSLVEAPVSTFPQ | 976 | Q5VYM1 | |
| DTSRVENLAASLPLP | 946 | O43593 | |
| TNASVPSIPLDVLSA | 606 | P08069 | |
| AENVSEALRAVPSPT | 1221 | Q5SYE7 | |
| VQSRPPSQAAVLSAS | 831 | Q96RV3 | |
| PSQAPITLAIDRANI | 996 | P51805 | |
| ESVPINTPLARLAAT | 726 | Q9NYQ8 | |
| QQPTALALEPDAIRS | 796 | Q9Y5F6 | |
| QVPFPRAEAASAVLS | 31 | Q02505 | |
| IETVAPNSPAAIADL | 396 | Q8NEN9 | |
| RPFNVTDVLTPAQLN | 136 | P05164 | |
| DDSRPALPSTQQLSV | 621 | P14543 | |
| LPRALAPAVTSQSVI | 796 | Q6ZU69 | |
| LPRALAPAVTSQSVI | 526 | Q63HN1 | |
| PTARTSQSQEPFLQL | 331 | Q9Y4A8 | |
| NLIFQVANTRPSPLT | 186 | O60928 | |
| LTASQLVPPDNQDTR | 1421 | P42356 | |
| EFLQARTPTLASTPI | 376 | P48681 | |
| GNAIPSSDQIRVAPS | 71 | P49257 | |
| ITTNQAAPSEVPTLR | 446 | P54753 | |
| SSLGDIPVSRVFQNP | 326 | Q9UJY4 | |
| SNTDLVPAPAVRILT | 76 | Q99988 | |
| PVLEPVAASSLAQRR | 721 | Q9UK32 | |
| PASQLPRDQLSALIQ | 66 | Q96KJ4 | |
| RAAAPDRTNPLNITL | 391 | O43301 | |
| IALEITVTNSPSNPR | 711 | P23229 | |
| SLQPRTTEALAAPAD | 536 | Q96FC9 | |
| SESFPSVNSRPNVIL | 11 | Q9H8H2 | |
| VVPASEPAARALDTQ | 306 | Q969F2 | |
| SPNQLVTPAASRLQL | 291 | O95800 | |
| PLIQAPLQAAAATTS | 776 | Q9Y3Q4 | |
| AEQSLNIASPPSLIL | 6461 | Q9UPN3 | |
| SPAIISIRQEPTNSQ | 891 | Q9Y5I2 | |
| LVSPSPSDQREAVAI | 466 | Q7RTS6 | |
| LPQVPVRSGSIEQAS | 1271 | Q86UR5 | |
| ARQELNTISSAPPQD | 296 | Q13349 | |
| VPTSTNQAQAAPEER | 216 | P51843 | |
| SPAIISIRQEPTNSQ | 906 | Q9H158 | |
| QLQARPSLATVQTPS | 356 | Q14686 | |
| APQIRSRSLAAQEPA | 471 | Q13415 | |
| RFNASQILSPSPEVR | 311 | Q4G163 | |
| ASVSAPKQILQPRAA | 681 | Q9Y4H2 | |
| STSILTDPAQLPEQA | 891 | Q9HAP2 | |
| ADQATPTNRLAALPK | 611 | O94856 | |
| LALRASTQAPAPTVN | 31 | Q9NZ94 | |
| LRLPEAAPDQANSLT | 671 | Q9Y5E2 | |
| APRPALLNSAENFTV | 176 | Q99572 | |
| PVEVAPSQLSAFRTL | 251 | P35218 | |
| APANAPLQRIRSTST | 201 | P10398 | |
| PTVPSLEAAQQLTRD | 696 | Q9NQ11 | |
| QLQQELRRSSAPFSP | 1996 | Q5TZA2 | |
| NSPLLSPRSNIDVNI | 516 | Q9HCM4 | |
| VSPRIESVNVAPENA | 761 | A0AVK6 | |
| ADVQQPLSQIPSDTA | 431 | Q6Y7W6 | |
| LLDVPTAAVQASPLQ | 16 | P13284 | |
| EIQNPVSANRSDPVT | 216 | P13688 | |
| SQPPENVRALSITSD | 1091 | Q8TD84 | |
| TAQARPSQILPLSQD | 981 | Q5SYB0 | |
| VIPAQNSADLPESTL | 446 | Q86XJ1 | |
| VLFISQRTEPPASTN | 1141 | Q9Y2H6 | |
| ELPLPRSQSISTQNV | 926 | Q9P278 | |
| NRPPDAVLTDTTSLN | 486 | P51659 | |
| AEVASALRSFSPLQP | 646 | Q7Z3C6 | |
| RSLSTAPVVQPLSIQ | 1071 | Q5TH69 | |
| ATQLAIQRATPETGP | 226 | Q9H972 | |
| PNPTLVTIARSSLDD | 391 | Q49AR2 | |
| LQSLQPRTTEALAAP | 536 | A8MPP1 | |
| AAPINSIVRSLDNSP | 1781 | Q8TDW7 | |
| VQSAQPLVDTRAPLT | 31 | A0A1B0GU71 | |
| RLRLSPDASPQQLVS | 1516 | Q9BZC7 | |
| DPEIPSAFNSLQRTL | 291 | Q9NX46 | |
| ICTAQNPVSQRSSLP | 221 | Q9HBG7 | |
| AQPETFPVAQALASR | 226 | Q9NTJ4 | |
| NERPVIFALSNPTAQ | 411 | P23368 | |
| SLQDPSQDSLAIIPS | 881 | O60336 | |
| LQPPRKAAASATVSV | 371 | Q8IXH8 | |
| ARLSPAVQPLNLSQT | 121 | Q9UKQ9 | |
| VPSQNPSRLAVISDS | 2941 | Q03164 | |
| LTELANIATSPQSPL | 111 | O60381 | |
| VAQADLELLTSSNPP | 6 | Q9H2J1 | |
| LNNRENISDPTSPLR | 66 | P01591 | |
| LNRTQSAPLPQSTLA | 446 | Q9UKV0 | |
| PQQSINEAIRTSTLP | 846 | P42261 | |
| ARSANAPPTSIALQV | 1696 | Q9Y238 | |
| NPVSASRSDPVTLNL | 221 | Q00888 | |
| QTIQAPPVSVSALAR | 271 | Q92622 | |
| NVTALPPTLANDTFR | 586 | Q8WWT9 | |
| AVTSIAPNITRGPLD | 396 | Q58EX2 | |
| VAVNQRSADALPAPV | 191 | Q9UJQ4 | |
| SVAPNDIPLVSSTNL | 341 | O43432 | |
| NSRRSPVPAQIAITV | 491 | O43432 | |
| PSEPNTAALQAALAR | 736 | Q8TEX9 | |
| ANSQEPEIRLTSSLP | 141 | Q9BUN1 | |
| VQRLTVTDLDAPNSP | 346 | P22223 | |
| QLPQFLSSPSQRTEV | 1396 | Q9C0B2 | |
| ATARAPPALVVTANI | 81 | F8WCM5 | |
| SPLALAPSSAIRDQR | 96 | Q8N4N8 | |
| NPVSASRSDPVTLNL | 221 | P11464 | |
| PSASALEQPATLQEV | 216 | Q13029 | |
| QQVPVSVRASLPSVA | 1116 | P98161 | |
| NPVSASRSDPVTLNL | 221 | Q16557 | |
| ISRQLASTLPAPLEN | 466 | Q8TB24 | |
| PQGTSQVPADLRISI | 306 | P33402 | |
| SLDQLVQALRATPDP | 246 | Q9UJJ7 | |
| PTIVSNSRDPAVQAA | 601 | Q92541 | |
| TAPRTVSVQTLNPLA | 386 | Q92750 | |
| RLQAPQASVTAPSEQ | 1031 | Q6WKZ4 | |
| EEISAAQPLLRPNSA | 521 | Q9UQF0 | |
| ESQRQAPELLVSPAS | 326 | Q9Y6M7 | |
| RNFTATPALADVLPQ | 171 | Q8IYR2 | |
| TPALADVLPQTLQRN | 176 | Q8IYR2 | |
| VLAAVLASQPSIPRS | 726 | Q96D71 | |
| QSPLPSLALSELSVQ | 241 | Q9Y365 | |
| NLASARTPAIPTAVN | 2241 | Q9UQ35 | |
| RTPAIPTAVNLADSR | 2246 | Q9UQ35 | |
| PTAVNLADSRTPAAA | 2251 | Q9UQ35 | |
| ASPRTAVAPSAVNLA | 2271 | Q9UQ35 | |
| NLPLSPQGTVRTAVE | 176 | Q9BX59 | |
| AQDEIPALSVSRPQT | 11 | P43686 | |
| VPQSLSPREDLAASV | 256 | B4DYI2 | |
| DVFSVSTPNLPQERL | 421 | B4DYI2 | |
| PSAAEINQAALLSIP | 281 | Q8TEL6 | |
| SILLNPDRQSPSALV | 766 | Q8TEL6 | |
| RLIFPITSQNPNELS | 571 | Q9P0V3 | |
| PAVANSSLQRSEPFV | 66 | Q6IEE7 | |
| PFSTSQVVARELLQP | 96 | Q6IEE7 | |
| AVSSDTLVAALQPTP | 231 | Q86TG1 | |
| RALASPEQLAQLPSS | 366 | Q9Y3Q8 | |
| TDILSRPVAAPNNSL | 56 | A6NJ46 | |
| QALPTQRLVVQSAAP | 171 | P22670 | |
| PASPQRVLVQAASSN | 26 | P48378 | |
| PVSASRSDPVTLNLL | 221 | Q00889 | |
| SLPVPESNLRTRNAI | 1666 | Q5UIP0 | |
| ARSQQIAAQLTTPPS | 151 | Q8N3V7 | |
| NPVSASRSDPVTLNL | 221 | Q00887 | |
| RASLPLAEQPTALTV | 2641 | Q6ZNJ1 | |
| VRTLSDVPSAAPQNL | 626 | Q92859 | |
| DVPSAAPQNLSLEVR | 631 | Q92859 | |
| ASPLPRSVDLSNNEA | 26 | Q7Z3Z4 | |
| TSLLQVRQDLPSPSD | 1941 | P48634 | |
| EPFSSNIANIPRDLV | 206 | Q9BZQ2 | |
| APIRSSLNSQQPTEE | 3066 | O75592 | |
| PPTLVQSASLLLNES | 3516 | P08F94 | |
| ATVSLRQNETPQPAA | 3271 | Q9P2P6 | |
| SSRSLQELNLSVEPP | 3331 | Q9P2P6 | |
| NPVSASRSDPVTLNL | 221 | Q13046 | |
| QDVFSVSTPNLPQER | 426 | P0DKV0 | |
| TVPQSPARAADSVLN | 386 | Q9NRH2 | |
| QSPSPLRLQLDRSQA | 71 | Q96JY6 | |
| RPPNTSLFIRNVADA | 6 | Q8WXF0 | |
| VELSPLTQASPQRAR | 1946 | Q9H2D6 | |
| AARSLQTPSARLVPA | 111 | Q9H6W3 | |
| QARAPPASLATVEAA | 451 | Q9NRC6 | |
| QQSRSPTFSEELPVL | 636 | Q8N0Z3 | |
| PAQSAATLPARTQET | 2181 | Q01082 | |
| AAQPLNLSSRPKTAE | 421 | P35712 | |
| LSPNPLNSRAVEDIS | 156 | Q13490 | |
| ASPTQPIQLSDLQSI | 256 | Q16186 | |
| FTAPTAIRAIRQQDP | 391 | Q9H6R3 | |
| PQALADANSTDPALI | 56 | Q7LGC8 | |
| LATRAQNLPQSPENT | 651 | Q8NE01 | |
| QPLRSQRSVPEAFSA | 31 | C9JXX5 | |
| DSELAQVSSPQLRNP | 271 | Q9BXT8 | |
| LVQRDVDASPSPLSV | 401 | Q8IWZ8 | |
| RTPASINATPANINL | 1531 | Q7KZ85 | |
| NQVAVSLSRPAPASR | 196 | Q5VWI1 | |
| SRLNDNVFATPSPII | 256 | Q8IX90 | |
| RAPLQSAVVTNAVSP | 421 | Q9HCE3 | |
| DAASRASELPRQQVP | 1026 | Q96KV7 | |
| NIASNQSRSPPAVVE | 421 | Q5T7W0 | |
| PRNVLTAIPSELFSS | 356 | Q9C0E2 | |
| ASQELQTLPRVPALS | 176 | P0CG00 | |
| QLNLSRLSVVAAPPV | 276 | Q5JS37 | |
| SEAELLPQLSRAPSQ | 531 | Q8NFH8 | |
| VLNPSGTQRSEPALA | 2196 | O15027 | |
| SVQSRLNLSIEVPSP | 921 | Q9UBZ9 | |
| ESPTLNPETVAINLS | 211 | P25445 | |
| RSSPAVEQQLLVSGP | 686 | O94956 | |
| LSALVVDLTPRNPNS | 536 | Q9NX95 | |
| VDLTPRNPNSAILLS | 541 | Q9NX95 | |
| QPSATLDAAQPRVTG | 66 | P08294 | |
| ELLRSAQPASAEPRQ | 621 | Q9Y490 | |
| QPDSPSAQLALIAAS | 976 | Q9Y490 | |
| SVNASSADEPIAPRL | 36 | Q8WZ71 | |
| ASSASRVQAILLPQP | 121 | Q8N9U9 | |
| AQDTQPSPLALLAAT | 51 | Q02447 | |
| AAPANTLAIVPDSRR | 1406 | Q9HCF6 | |
| TAAQTVPTALSPQDL | 921 | A6NE52 | |
| SRALSPLSPVAIEQT | 601 | Q96K83 | |
| PSAAISIQRPAQSRD | 326 | Q9H0E3 | |
| LDPPANLTASEVTRQ | 1041 | Q92752 | |
| NLSRLTDTLPAPEVS | 271 | Q6ZS81 | |
| ITNISSSDAPLQPLV | 136 | Q8IYB5 | |
| LQPLVSSPSLQAAVD | 146 | Q8IYB5 | |
| IIPQSSVSPNAVIAD | 1766 | Q709C8 | |
| SNPELVRAVTLEAPF | 571 | Q4J6C6 | |
| VEQDSSQPSLPLVRA | 826 | Q12888 | |
| PAVINSRVSAISLPT | 116 | P07478 | |
| VARNPVSRNFSSPIL | 196 | Q9NQ25 | |
| LLVSDPSEAQRLTPA | 81 | A0A2R8Y7D0 | |
| QLSLPRFPSVSLQEA | 101 | Q16378 | |
| RAAPLQEAVPRTQAT | 431 | P85298 | |
| RPTAQVLPVQNEASS | 471 | Q8WYQ9 | |
| LPAARLPTTVLNATA | 326 | Q9GZM5 | |
| TVDNIPPLAASVEQT | 981 | Q9NS56 | |
| PSSSNIAAPVEQLLV | 331 | Q9ULD9 | |
| SAALARNNSRVSPVP | 2161 | Q96JM2 | |
| ALQPPEFRNESSLAS | 11 | Q3ZAQ7 | |
| ALPQEVSIAASRPSR | 136 | Q96JP5 | |
| PVQLLTIRVASTNPA | 206 | A0AVI4 | |
| QVRLSNPSPVEGASV | 151 | P0DP72 | |
| VSNLNPERVTPQSLF | 341 | P26599 | |
| EASRPNTALISPENL | 706 | Q9Y4E6 | |
| LSEARSLLNPQDTPV | 1871 | Q5VUA4 | |
| DAATVPSLAAPQALT | 81 | Q8N228 | |
| SLPPNLAVAEQEASV | 201 | Q6P2D8 | |
| VSTAPDLQSLAAVPT | 171 | Q8IV31 | |
| QPTLLPNNTVFSRVE | 1176 | Q14202 | |
| RQDTQLPQESALLPA | 21 | Q5JNZ3 | |
| AFAIQEPSPRESLQV | 26 | Q6UXF1 | |
| TRAIAQPQLLTFPDS | 76 | Q8N9L7 | |
| PQDTTALESLIPSAN | 951 | O94898 | |
| ALESLIPSANREPSA | 956 | O94898 | |
| RSNLTSLLVQPISAP | 371 | Q58DX5 | |
| NSRSAVVELPAAVQP | 61 | Q96RE7 | |
| TRLDVTARPNQTLPA | 436 | Q9UBF9 | |
| IAGRSEPATLAQPVT | 816 | Q14324 | |
| SRIQNPVAFLSSVLP | 821 | Q86TC9 |